Clinical and internal medicine Books
John Wiley and Sons Ltd How to Promote Wellbeing
Book SynopsisHow to Promote Wellbeing is a timely resource designed to help all healthcare practitioners promote and protect their own and their patients'' wellbeing and mental health. Focusing on practical strategies and guidance, this much-needed book explores approaches for reducing burnout, managing stress, coping with pressure in healthcare settings, recognising signs of impaired decision-making, and much more. Written specifically for busy healthcare practitioners, the book offers focused and succinct chapters on topics ranging from behaviours to improve resilience and mindfulness, to approaches for maintaining work-life balance when confronted with excessive workloads and organisational pressures. Throughout the text, evidence-based tools and techniques are provided to improve the practitioner''s health and facilitate the delivery of high-quality care. Covering a wide range of clinical situations and important issues, this book: Examines global, organisational, Trade Review“In 'How to Promote Wellbeing', Dr Rachel Thomas has produced a timely resource designed to help all healthcare practitioners promote and protect their own wellbeing and mental health. From her own clinical medical background of neuroscience and the psychology of mental health, she provides practical strategies and guidance: by providing care to another human being, she explores how this can affect the carer … This mental health first aid tool should be in your department's library and in the hands of those with an educational or leader's role, caring for staff welfare and your wellbeing.” – Journal of Perioperative PracticeTable of ContentsAbout the author ix Acknowledgements x Preface xi Introduction 1 Learning outcomes 2 Why should we be concerned about our own wellbeing? 3 Why should we consider both problem factors and protective factors? 5 Chapter 1 General problem factors affecting global mental health and wellbeing 7 Problem factor: Global mental health burden 7 Problem factor: Accessing resources 9 Problem factor: Multiple potential impacts on individual mental health 11 Problem factor: The acute and chronic stress responses 12 Problem factor: The diathesis-stress model 15 Problem factor: Stigma 16 Chapter 2 Problem factors affecting healthcare practitioner mental health and wellbeing 19 Problem factor: Perceptions of invulnerability 19 Problem factor: Presenteeism 20 Problem factor: Perceptions of hierarchy 22 Problem factor: Burnout 23 Problem factor: Compassion fatigue 30 Problem factor: Perfectionistic personality traits 33 Problem factor: Lack of recovery behaviours 34 Problem factor: Sleep cycle derangement and sleep deprivation 35 Chapter 3 Problem and protective factors affecting patients' mental health and wellbeing 37 Factor to consider: The interlinkage of mental and physical health 37 Factor to consider: Sleep 40 Factor to consider: Diet 42 Factor to consider: Cognitive aspects 42 Chapter 4 Protective factors for organisational implementation 44 Protective factor: Organisational resilience 45 Protective factor: Organisational approaches to addressing stigmatisation 49 Protective factor: Creating a culture of support 50 Protective factor: Facilitating access and awareness of support avenues 53 Protective factor: Promoting communication 54 Protective factor: Balancing the psychosocial safety climate 55 Protective factor: Implementing a wellbeing strategy 58 Chapter 5 Protective factors for individual implementation 60 Protective factor: Learning a new wellbeing skill 60 Protective factor: Defining motivation to change 62 Protective factor: Individual resilience 63 Protecting factor: Compassion satisfaction and self-care 64 Protective factor: Promoting individual action 68 Protective factor: Awareness and mitigation of risk factors for burnout 69 Protective factor: Recognising and intervening approaching burnout and compassion fatigue 70 Protective factor: Connection 73 Protective factor: Access to support 73 Protective factor: Judicious use of standardised processes and templates 76 Protective factor: Practising self-awareness and meditation/mindfulness 77 Protective factor: Adequate sleep 78 Protective factor: Balanced diet 81 Protective factor: Adequate hydration 83 Protective factor: Optimising thinking styles 84 Protective factor: Appropriate delegation 90 Protective factor: Reflection on personal accomplishment 92 Protective factor: Physical activity 93 Protective factor: Gratitude practices 94 Chapter 6 Protective factors for individual trainee/student implementation 95 Protective factor: Medical school education styles 95 Protective factor: Good habits around maintaining patient confidentiality 96 Protective factor: Maintaining thorough record keeping 97 Protective factor: Maintaining clear communication 98 Protective factor: Planning training requirements 99 Chapter 7 Emergencies in mental health and wellbeing 100 Professional emergency: Pandemics 100 Professional emergency: Patient mental health 101 Professional emergency: Whistleblowing 102 Personal emergency: Personal crisis 105 Chapter 8 Mental health and wellbeing toolkit 106 Reframing 107 Weighing the evidence 107 Softening black-and-white thinking 107 Focusing on the benefits 107 Journaling 108 Reflecting 108 Challenging thought processes 108 Pausing 108 Delegating 108 Working as a team 109 Noticing anticipatory stress 109 Accepting 'good enough' 109 Replacing 'should' and 'must' 109 Playing out 'what if. . .?' 110 Connecting 110 Mentoring and buddying-up 110 Being thankful 110 Feeling a sensation 111 Progressively relaxing our muscles 111 Progressively mentally scanning our body 111 Deep breathing 111 Focusing on a physical sensation 112 Moving 112 Drinking de-caffeinated drinks after 3pm 112 Removing blue light after 8pm 112 Prioritising sleep 112 Starting and keeping to a regular sleep schedule 113 Drinking enough water 113 Eating well 113 Sitting less 113 Going outside 113 Talking 114 Accessing online resources 114 References 115 Index 130
£31.30
John Wiley and Sons Ltd Assisted Reproduction Techniques
Book SynopsisAssisted reproduction techniques have led to the birth of 8 million babies worldwide Assisted reproduction techniques (ART), in particular in-vitro fertilization and intra-cytoplasmic sperm injection, are the most advanced forms of infertility treatment. They involve numerous counseling, medical, surgical and laboratory-based steps. At each step various problems and complications could be encountered that challenge even the most experienced ART practitioners. Moreover, patients with complex medical disorders may require ART, presenting further challenges. Assisted Reproduction Techniques will stimulate resourceful thinking in the ART practitioner when faced with these challenges. It outlines various management options, the reasoning behind them, and the evidence on which they are based to enable the practitioner to choose the most suitable solution for the needs of each patient. Written by 171 internationally renowned experts, Assisted ReproductTable of ContentsContributors xiii Preface to the second edition xxviii Preface to the first edition xxix How to use this book xxx Abbreviations xxxi Section 1: Counseling and preparation 1 1 Risk of cancer from ovarian stimulation 3Yadava Jeve 2 Risk of early menopause following IVF treatment 9Sesh Kamal Sunkara 3 The HIV-positive female 12Mark V. Sauer and Shelley Dolitsky 4 The HIV-positive male 19Mark V. Sauer and Shelley Dolitsky 5 The hepatitis B or C carrier patient 26Justin Chu 6 The patient with cystic fibrosis 32Tarek El‐Toukhy 7 The patient on medication 37Pedro Melo and Arri Coomarasamy 8 The patient with thrombophilia 48Yorain Sri Ranjan and Ying C. Cheong 9 The patient with autoimmune disorders 56Giulia Mariani and José Bellver 10 The patient with malignant disease: fertility preservation 61Arri Coomarasamy and Manal Elgendy 11 The patient with heart disease 69Anna S. Herrey and Catherine Nelson-Piercy 12 The patient with diabetes 75Mohammed A. Khan, Neelam Potdar, and Justin C. Konje 13 The patient with thyroid disease 81Shiao-yng Chan 14 The patient with hyperprolactinemia 89John Ayuk 15 The patient with polycystic ovaries 96Adam H. Balen 16 The renal transplant patient 103Justin Chu and Lynne Robinson 17 The patient with previous pelvic irradiation 110Vishvanath C. Karande 18 Female fertility after chemotherapy 116Nivedita Reddy 19 The patient with abnormal cervical cytology 123Martyn Underwood and William Rhys Parry-Smith 20 The patient with previous borderline ovarian tumor 127Arri Coomarasamy, Kavita Singh, and Jennifer Tamblyn 21 The patient with an endometrioma 132Spyros Chouliaras and Luciano G. Nardo 22 The patient with cervical stenosis 137Khaldoun Sharif 23 Vaccination and ART 142Arri Coomarasamy and Rima Dhillon-Smith 24 The patient with hydrosalpinx 147Annika Strandell 25 The patient with hydrosalpinx and contraindication to laparoscopy 153Basim Abu-Rafea 26 The patient with reduced ovarian reserve 159Scott M. Nelson 27 The patient with congenital uterine anomalies 166Rima Dhillon-Smith and Pallavi Latthe 28 The patient with congenital cervico-vaginal anomalies 171Rima Dhillon-Smith and Pallavi Latthe 29 The patient with uterine fibroids 176Kugajeevan Vigneswaran and Haitham Hamoda 30 The patient with adenomyosis 182Andreas Athanasakis and Arri Coomarasamy 31 The patient with previous Essure® sterilization 187T. Justin Clark 32 The patient with previous endometrial ablation 192T. Justin Clark 33 The couple with recurrent implantation failure 200Lukasz Polanski and Yakoub Khalaf 34 The patient with previous uterine artery embolization 207Kugajeevan Vigneswaran and Haitham Hamoda 35 The patient with endometrial polyp 212Arri Coomarasamy and Laurentiu Craciunas 36 The obese female patient 217Mostafa Metwally and Bolarinde Ola 37 The patient with Asherman syndrome 223Alessandro Conforti, Giuseppe Iorio, and Carlo Alviggi 38 The older patient 228Giselle Crawford and William Ledger 39 Requests for mild or natural cycle IVF treatment 234Brad B. Swelstad and Suheil J. Muasher 40 The patient with psychosexual problems 239Penny Goold and Elizabeth Howland 41 The patient needing third-party reproduction 246Imad Aboujaoude and Teddy Tadros 42 Social oocyte freezing 252Valerie L. Peddie and Smriti Ray Chaudhuri Bhatta 43 The male and female patients following bariatric surgery 258Zaher Merhi and Ali Ahmed Bazzi 44 Endometrial receptivity testing 265Laurentiu Craciunas and Arri Coomarasamy Section 2: Pituitary suppression and ovarian stimulation phase 271 45 Poor response during ovarian stimulation 273Pedro Melo, Lynne Robinson, and Arri Coomarasamy 46 Ovarian stimulation for IVF in a patient at high risk of ovarian hyperstimulation syndrome 279Khaldoun Sharif and Ahmed G. Serour 47 Unable to achieve pituitary down-regulation 284K. Jayaprakasan and Nicholas Raine-Fenning 48 The patient discovered pregnant during pituitary down-regulation 291Mohammed Khairy Mahmoud and Arri Coomarasamy 49 Ovarian cysts following pituitary down-regulation 296Alison Taylor 50 Missed IVF medications 302Pedro Melo, Lynne Robinson, and Arri Coomarasamy 51 The ART patient with a history of estrogen-receptorpositive cancer 309 Murat Sönmezer and Volkan Turan52 The patient over-responding to controlled ovarian stimulation during IVF 315Khaldoun Sharif Section 3: Oocyte retrieval 323 53 General anesthesia or sedation for oocyte retrieval? 325Claire Scanlon and David Green 54 Delayed oocyte retrieval 331Khaldoun Sharif 55 Empty follicle syndrome 337Aboubakr Mohamed Elnashar 56 Bleeding following oocyte retrieval 344Annika K. Ludwig and Barbara Sonntag 57 To flush or not to flush follicles at oocyte retrieval 351Anne E. Martini and Micah J. Hill 58 Inaccessible ovaries at oocyte retrieval 358Aboubakr Mohamed Elnashar 59 Endometriotic cysts at oocyte retrieval 363Graciela Kohls Ilgner and Juan Antonio García-Velasco 60 Inadvertent injury during oocyte retrieval 369Khaldoun Sharif 61 Dealing with equipment failure during oocyte retrieval 377Isla Robertson and Ying C. Cheong Section 4: Embryo transfer 381 62 How many embryos to transfer? 383Ellen Armstrong and Arri Coomarasamy 63 Poor endometrial development in ART 390Jyotsna Pundir and Arri Coomarasamy 64 Endometrial cavity fluid identified during IVF treatment 400Arri Coomarasamy and Yealin Chung 65 Difficult embryo transfer 404Khaldoun Sharif 66 Excess cervical mucus and retained embryos at embryo transfer 413Hassan N. Sallam, Ahmed F. Galal, and Fady S. Moeity 67 Life after embryo transfer 419Kelton Tremellen Section 5: The luteal phase 427 68 Vaginal bleeding in the luteal phase after IVF 429Carol Coughlan and Bolarinde Ola 69 Pelvic infection after IVF 435Muhammad Faisal Aslam and Ali Ahmad Bazzi 70 The patient presenting with ovarian hyperstimulation syndrome 440Khaldoun Sharif and Dania Al‐Ramahi 71 Adnexal torsion after IVF 447Jenna Turocy and Beth W. Rackow 72 Exposure to infection in the luteal phase of IVF 453Pedro Melo and Arri Coomarasamy Section 6: The ART laboratory 465 73 Total failure of fertilization after conventional IVF – rescue ICSI 467A. Albert Yuzpe 74 Couples not wishing to create surplus embryos in IVF 473Hossam Mohamed 75 Routine preimplantation genetic testing for aneuploidy 478Lukasz Polanski and Yakoub Khalaf 76 Choosing an embryo for transfer 484Peter Kovacs and Szabolcs Matyas 77 Globozoospermia 492Odai A. M. Alqawasmeh and Christopher L. R. Barratt 78 Total failure of fertilization after ICSI 498Kaoru Yanagida 79 Refreezing of embryos 503Jerome H. Check and Donna Summers 80 Infection in embryo culture medium 509Alison Campbell and Louise Best 81 ICSI or IVF for nonmale-factor infertility? 515Samuel Dobson and Bolarinde Ola 82 Cryostorage failure in ART 522Christopher P. Moutos, Angela H. Liu, and John Y. Phelps 83 The ART program during a disaster 527Richard P. Dickey and Carla Ball White 84 Using the wrong sperm or embryos in IVF 533Khaldoun Sharif and Majd M. Ezal‐Deen Section 7: The male patient 539 85 Unexpected inability to produce a semen sample on the day of oocyte retrieval 541Khaldoun Sharif, Majd M. Ezal‐Deen, and Gyath Karadsheh 86 The azoospermic patient 545Khaldoun Sharif and Ali Al-Rawahneh 87 ART in men with Klinefelter syndrome 553Medhat Amer and Emad Fakhry 88 ART in men with 100% immotile sperm 559Jose Vázquez Núñez, Juan José Artazkoz Marques de Oliveira, Patricia Hernández Delgado, Ayrton Artazkoz Marques de Oliveira, and Neuda Marques de Oliveira 89 Request for posthumous fatherhood with perimortem surgical sperm retrieval 565Mahmoud Mima, Samuel J. Ohlander, Rodrigo L. Pagani, Heather E. Ross, and Lawrence S. Ross 90 Retrograde ejaculation and anejaculation 575Hussain M. Alnajjar and Asif Muneer 91 Sperm retrieval in cancerous testes 580Wael Almajed, Saad Aldousari, and Armand Zini 92 Leukocytospermia and ART 584Giuseppe Ricci 93 The infertile male patient with a genetic cause 589Marlon P. Martinez and Ashok Agarwal 94 Y chromosome microdeletions and ART 598Sherman J. Silber and Sierra Goldsmith 95 DNA fragmentation, antioxidants and ART 606Sarah J. Martins da Silva Section 8: The ART pregnancy 613 96 Unexpected number or sex of babies after IVF 615Majd M. Ezal-Deen, Mohamad Bani-Domi, and Omar Sharif 97 Suspected ectopic pregnancy after IVF 620Vishvanath C. Karande, Liselotte Mettler,, and Ibrahim Alkatout 98 Cervical ectopic pregnancy after IVF 626Usha Verma and Sabrina Pastor-Carvajal 99 Heterotopic pregnancy after IVF 632Abdel‐Maguid Ramzy 100 Multifetal pregnancy reduction after IVF 638Omar Taso and Maher Maaita 101 Multiple pregnancy after IVF: how to reduce preterm delivery 644Shawqi Saleh and Maysa Khadra 102 Hyperreactio luteinalis after IVF 650Muataz Al-Ramahi and Omar Sharif 103 Lactation by a commissioning mother in surrogacy 654Pavithra Rao and Frank P. Biervliet 104 Children of ART 658Defne Saatci and Alastair G. Sutcliffe Section 9: General and organizational issues 665 105 Managing physical symptoms during IVF 667Chiara Achilli and Jyotsna Pundir 106 IVF when the prognosis is very poor or futile 673Khaldoun Sharif 107 Dealing with the emotional distress following failed IVF 678Sarah R. Holley, Lauri A. Pasch, and Alice D. Domar 108 Couple splitting while embryos are in storage 684Masoud Afnan 109 Unexpected drop in the IVF clinic pregnancy rate 690Bulent Urman and Kayhan Yakin 110 Natural fertility after IVF 696Frank Nawroth and Annika K. Ludwig 111 Training in ART 699Ryan J. Heitmann 112 Keeping up to date in ART practice 706Bassel H. Al-Wattar and Khalid S. Khan 113 Cross-border reproductive care 714Mahmoud Salama, Lynn M. Westphal, Marcia C. Inhorn, and Pasquale Patrizio 114 Satellite and transport ART treatment 720M. F. González Echeverría and J. A. Blaquier 115 Social media use in ART 725Natalie M. Crawford, Roohi Jeelani, Lora K. Shahine, and Kenan Omurtag 116 Managing an ART unit as a profitable business 733Michael H. Fakih, Ahmad Fakih, and Amanda Fakih Index 739
£148.45
John Wiley & Sons Inc The Patient Equation
Book SynopsisHow the data revolution is transforming biotech and health care, especially in the wake of COVID-19and why you can't afford to let it pass you by We are living through a time when the digitization of health and medicine is becoming a reality, with new abilities to improve outcomes for patients as well as the efficiency and success of the organizations that serve them. In The Patient Equation, Glen de Vries presents the history and current state of life sciences and health care as well as crucial insights and strategies to help scientists, physicians, executives, and patients survive and thrive, with an eye toward how COVID-19 has accelerated the need for change. One of the biggest challenges facing biotech, pharma, and medical device companies today is how to integrate new knowledge, new data, and new technologies to get the right treatments to the right patients at precisely the right timesmade even more profound in the midst of a pandemic and in the years to cTable of ContentsIntroduction vii Section 1 From Hippocrates to Epocrates 1 Chapter 1 Before We Cured Scurvy 3 Chapter 2 Inside the Equations 17 Chapter 3 Fitbits, Smart Toilets, and a Bluetooth-enabled Self-driving ECG 43 Section 2 Applying Data to Disease 57 Chapter 4 Ava—Tracking Fertility, on the Road Toward Understanding All of Women’s Health 59 Chapter 5 One Breath, One Drop—Asthma and Diabetes, Chronic Conditions Being Conquered with Technology 69 Chapter 6 Flumoji and Sepsis Watch—Two Approaches to Predicting and Preventing Acute, Life-threatening Conditions Through Smarter Data 81 Chapter 7 Cancer and Phage Therapy—Crafting Custom Treatments Just for You 93 Chapter 8 Castleman Disease—Not One Rare Disease with No Treatments, But Three Rare Diseases . . . with Hope, Thanks to Data 105 Section 3 Building Your Own Patient Equations 113 Chapter 9 The Steam Table 115 Chapter 10 Good Data 133 Chapter 11 Changing Clinical Trials 143 Chapter 12 Disease Management Platforms 175 Section 4 Scaling Progress to the World 191 Chapter 13 The Importance of Collaboration 193 Chapter 14 Value-based Reimbursement 203 Chapter 15 Aligning Incentives 217 Conclusion 231 Acknowledgments 241 About the Authors 243 Index 245
£19.54
John Wiley and Sons Ltd Bioethics
Book SynopsisThe new edition of the classiccollectionofkeyreadings in bioethics, fullyupdated to reflect the latest developmentsandmain issues inthe field For more than two decades, Bioethics: An Anthology has been widely regarded as the definitive single-volume compendium of seminal readings on both traditional and cutting-edge ethical issues in biology and medicine. Acclaimed for its scope and depth of coverage, this landmark work brings together compelling writings by internationally-renowned bioethicist to help readers develop a thorough understanding of the central ideas, critical issues, and current debate in the field. Now fully revised and updated,thefourth editioncontains a wealth of newcontentonethical questionsand controversies related tothe COVID-19 pandemic,advances inCRISPRgene editing technology, physician-assisted death,public health and vaccinations,transgender children,medical aid in dying,the morality of ending the lives of newborns,and much Table of ContentsAcknowledgments xiii Introduction 1 Part I Abortion 9 Introduction 11 1 Abortion and Infanticide 15Michael Tooley 2 A Defense of Abortion 31Judith Jarvis Thomson 3 The Wrong of Abortion 42Patrick Lee and Robert P. George 4 Why Abortion is Immoral 54Don Marquis Part II Issues in Reproduction 67 Introduction 69 Assisted Reproduction 73 5 The McCaughey Septuplets: God's Will or Human Choice? 75Gregory Pence 6 The Meaning of Synthetic Gametes for Gay and Lesbian People and Bioethics Too 78Timothy F. Murphy 7 Rights, Interests, and Possible People 85Derek Parfit Prenatal Screening, Sex Selection, and Cloning 91 8 Genetics and Reproductive Risk: Can Having Children Be Immoral? 93Laura M. Purdy 9 Sex Selection and Preimplantation Genetic Diagnosis 101The Ethics Committee of the American Society of Reproductive Medicine 10 Sex Selection and Preimplantation Diagnosis: A Response to the Ethics Committee of the American Society of Reproductive Medicine 107Julian Savulescu and Edgar Dahl 11 Why We Should Not Permit Embryos to Be Selected as Tissue Donors 110David King 12 The Moral Status of Human Cloning: Neo-Lockean Persons versus Human Embryos 115Michael Tooley Part III Genetic Manipulation 133 Introduction 135 13 Questions about Some Uses of Genetic Engineering 139Jonathan Glover 14 The Moral Significance of the Therapy-Enhancement Distinction in Human Genetics 151David B. Resnik 15 In Defense of Posthuman Dignity 162Nick Bostrom 16 Statement on NIH Funding of Research Using Gene-Editing Technologies in Human Embryos 170Francis S. Collins 17 Genome Editing and Assisted Reproduction: Curing Embryos, Society or Prospective Parents? 172Giulia Cavaliere 18 Who's Afraid of the Big Bad (Germline Editing) Wolf? 185R. Alta Charo 19 An Ethical Pathway for Gene Editing 191Julian Savulescu and Peter Singer Part IV Life and Death Issues 195 Introduction 197 20 The Sanctity of Life 207Jonathan Glover 21 Declaration on Euthanasia 218Sacred Congregation for the Doctrine of the Faith Killing and Letting Die 223 22 Active and Passive Euthanasia 225James Rachels 23 The Morality of Killing: A Traditional View 230Germain Grisez and Joseph M. Boyle, Jr. 24 Is Killing No Worse Than Letting Die? 235Winston Nesbitt 25 Why Killing is Not Always Worse - and Sometimes Better - Than Letting Die 240Helga Kuhse 26 Moral Fictions and Medical Ethics 244Franklin G. Miller, Robert D. Truog, and Dan W. Brock Newborns 255 27 Can a Physician Ever Justifiably Euthanize a Severely Disabled Newborn? 257Robert M. Sade 28 No to Infant Euthanasia 259Gilbert Meilaender 29 Physicians Can Justifiably Euthanize Certain Severely Impaired Neonates 262Udo Schuklenk 30 You Should Not Have Let Your Baby Die 266Gary Comstock 31 After-Birth Abortion: Why Should the Baby Live? 269Alberto Giubilini and Francesca Minerva 32 Does a Human Being Gain the Right to Live after He or She is Born? 275Christopher Kaczor 33 Hard Lessons: Learning from the Charlie Gard Case 280Dominic Wilkinson and Julian Savulescu Brain Death 289 34 A Definition of Irreversible Coma 291Report of the Ad Hoc Committee of the Harvard Medical School to Examine the Definition of Brain Death 35 The Challenge of Brain Death for the Sanctity of Life Ethic 296Peter Singer 36 The Philosophical Debate 308The President's Council on Bioethics 37 An Alternative to Brain Death 318Jeff McMahan Advance Directives 323 38 Life Past Reason 325Ronald Dworkin 39 Dworkin on Dementia: Elegant Theory, Questionable Policy 333Rebecca Dresser Voluntary Euthanasia and Medically Assisted Suicide 343 40 The Note 345Chris Hill 41 When Self-Determination Runs Amok 350Daniel Callahan 42 When Abstract Moralizing Runs Amok 356John Lachs 43 Physician-Assisted Death and Severe, Treatment-Resistant Depression 361Bonnie Steinbock 44 Are Concerns about Irremediableness, Vulnerability, or Competence Sufficient to Justify Excluding All Psychiatric Patients from Medical Aid in Dying? 378William Rooney, Udo Schuklenk, and Suzanne van de Vathorst Part V Resource Allocation 393 Introduction 395 45 In a Pandemic, Should We Save Younger Lives? 399Peter Singer and Lucy Winkett 46 The Value of Life 403John Harris 47 Bubbles under the Wallpaper: Healthcare Rationing and Discrimination 413Nick Beckstead and Toby Ord 48 Rescuing Lives: Can't We Count? 420Paul T. Menzel 49 Should Alcoholics Compete Equally for Liver Transplantation? 423Alvin H. Moss and Mark Siegler Part VI Obtaining Organs 431 Introduction 433 50 Organ Donation and Retrieval: Whose Body is it Anyway? 435Eike-Henner W. Kluge 51 The Case for Allowing Kidney Sales 439Janet Radcliffe-Richards, A. S. Daar, R. D. Guttmann, R. Hoffenberg, I. Kennedy, M. Lock, R. A. Sells and N. Tilney and for the International Forum Transplant Ethics 52 Ethical Issues in the Supply and Demand of Kidneys 443Debra Satz 53 The Survival Lottery 456John Harris Part VII Ethical Issues in Research 463 Introduction 465 Experimentation with Humans 473 54 Belmont Report: Ethical Principles and Guidelines for the Protection of Human Subjects of Research 475National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research 55 Scientific Research is a Moral Duty 483John Harris 56 Participation in Biomedical Research is an Imperfect Moral Duty: A Response to John Harris 495Sandra Shapshay and Kenneth D. Pimple 57 Unethical Trials of Interventions to Reduce Perinatal Transmission of the Human Immunodeficiency Virus in Developing Countries 501Peter Lurie and Sidney M. Wolfe 58 We're Trying to Help Our Sickest People, Not Exploit Them 507Danstan Bagenda and Philippa Musoke-Mudido 59 Pandemic Ethics: The Case for Risky Research 510Peter Singer and Richard Yetter Chappell Experimentation with Animals 515 60 Duties towards Animals 517Immanuel Kant 61 A Utilitarian View 519Jeremy Bentham 62 The Harmful, Nontherapeutic Use of Animals in Research is Morally Wrong 521Nathan Nobis 63 The Use of Nonhuman Animals in Biomedical Research 535Dario L. Ringach 64 Ethical Issues When Modelling Brain Disorders in Non-Human Primates 550Carolyn P. Neuhaus Academic Freedom and Research 559 65 On Liberty 561John Stuart Mill 66 Should Some Knowledge Be Forbidden?: The Case of Cognitive Differences Research 566Janet A. Kourany 67 Academic Freedom and Race: You Ought Not to Believe What You Think May Be True 575James R. Flynn Part VIII Public Health Issues 585 Introduction 587 68 Ethics and Infectious Disease 591Michael J. Selgelid 69 XDR-TB in South Africa: No Time for Denial or Complacency 602Jerome Amir Singh, Ross Upshur, and Nesri Padayatchi 70 Clinical Ethics During the Covid-19 Pandemic: Missing the Trees for the Forest 612Vijayaprasad Gopichandran 71 The Moral Obligation to be Vaccinated: Utilitarianism, Contractualism, and Collective Easy Rescue 620Alberto Giubilini, Thomas Douglas, and Julian Savulescu 72 Taking Responsibility for Responsibility 638Neil Levy Part IX Ethical Issues in the Practice of Healthcare 651 Introduction 653 When do Doctors have a Duty to Treat? 659 73 What Healthcare Professionals Owe Us: Why Their Duty to Treat During a Pandemic is Contingent on Personal Protective Equipment (PPE) 661Udo Schuklenk 74 Conscientious Objection in Health Care 667Mark R. Wicclair 75 Conscientious Objection in Medicine: Accommodation versus Professionalism and the Public Good 682Udo Schuklenk Confidentiality 693 76 Confidentiality in Medicine: A Decrepit Concept 695Mark Siegler 77 A Defense of Unqualified Medical Confidentiality 699Kenneth Kipnis Truth-Telling 713 78 On a Supposed Right to Lie from Altruistic Motives 715Immanuel Kant 79 Should Doctors Tell the Truth? 717Joseph Collins 80 On Telling Patients the Truth 724Roger Higgs Informed Consent and Patient Autonomy 731 81 On Liberty 733John Stuart Mill 82 From Schloendorff v. NewYork Hospital 736Justice Benjamin N. Cardozo 83 Informed Consent: Its History, Meaning, and Present Challenges 737Tom L. Beauchamp 84 The Doctor-Patient Relationship in Different Cultures 745Ruth Macklin 85 Transgender Children and the Right to Transition: Medical Ethics When Parents Mean Well But Cause Harm 758Maura Priest 86 Amputees by Choice 777Carl Elliott 87 Rational Desires and the Limitation of Life-Sustaining Treatment 788Julian Savulescu Part X Disability 807 Introduction 809 88 Valuing Disability, Causing Disability 811Elizabeth Barnes 89 Is Disability Mere Difference? 829Greg Bognar 90 Prenatal Diagnosis and Selective Abortion: A Challenge to Practice and Policy 835Adrienne Asch 91 Down Syndrome Screening Isn't about Public Health: It's about Eliminating a Group of People 851Renate Lindeman 92 I Would've Aborted a Fetus with Down Syndrome: Women Need that Right 854Ruth Marcus Part XI Neuroethics 857 Introduction 859 93 Neuroethics: Ethics and the Sciences of the Mind 861Neil Levy 94 Engineering Love 867Julian Savulescu and Anders Sandberg 95 Unrequited Love Hurts: Should Doctors Treat Broken Hearts? 870Francesca Minerva 96 Stimulating Brains, Altering Minds 876Walter Glannon 97 Authenticity or Autonomy? When Deep Brain Stimulation Causes a Dilemma 883Felicitas Kraemer 98 On the Necessity of Ethical Guidelines for Novel Neurotechnologies 889Sara Goering and Rafael Yuste Index 895
£52.20
John Wiley and Sons Ltd Protocols for HighRisk Pregnancies
Book SynopsisThrough seven editions, Protocols for High-Risk Pregnancies has helped busy obstetricians keep pace with a constantly evolving field. Providing just-in-time content, its focus on protocols and guidelines helps organize medical thinking, avoid heuristic errors of omission and commission, and optimize maternal and fetal outcomes. As with the prior six editions, the editors have once again assembled some of the world's top obstetrical and medical experts. This seventh edition has also been expanded to include a number of new topics, including: Protocols on opioid use, misuse and addition in pregnancy and postpartum Noninvasive prenatal diagnosis of aneuploidy Periconceptual genetic screening Expanded protocols on maternal valvular heart disease and cardiomyopathies Protocols on arboviruses, including Zika and malaria Protocols for High-Risk Pregnancies: An Evidence-Based Approach will be an essential reTable of ContentsPreface ix List of Contributors xi Part 1 Concerns in Pregnancy 1 Alcohol Use in Pregnancy and Lactation 3Ruta M. Nonacs 2 Smoking, Vaping, and Nicotine Exposure 9John Byrne and George Saade 3 Opioid Use, Misuse, and Addiction in Pregnancy and Postpartum 15Mishka Terplan 4 Depression 21Kimberly Yonkers Part 2 Antenatal Testing 5 Prenatal Testing for Chromosomal Abnormalities 29Mary E. Norton 6 Fetal Echocardiography 41Joshua A. Copel 7 Clinical Use of Doppler 49Henry L. Galan 8 Antepartum Testing 61Michael P. Nageotte 9 Fetal Blood Sampling and Transfusion 69Patricia Santiago‐Munoz 10 Preconception Genetic Screening 77Lauren Sayres and Jeffrey A. Kuller Part 3 Maternal Disease 11 Maternal Anemia 89Elaine Duryea 12 Hemoglobinopathies in Pregnancy 97Bradley Sipe and Judette Louis 13 Fetal and Neonatal Alloimmune Thrombocytopenia 105Russell Miller and Richard Berkowitz 14 Rheumatological Disorders 113Lisa R. Sammaritano and Bonnie L. Bermas 15 Antiphospholipid Syndrome 125Robert M. Silver 16 Inherited Thrombophilias 131Andra H. James and Jerome J. Federspiel 17 Valvular Heart Disease in Pregnancy 141Blake Zwerling and Afshan B. Hameed 18 Peripartum Cardiomyopathy 165Sarah Rae Easter and Carolyn M. Zelop 19 Thromboembolism 181Michael J. Paidas 20 Renal Disease 201Shivani Patel 21 Obesity 209Patrick S. Ramsey 22 Diabetes Mellitus 219Mark B. Landon and Steven G. Gabbe 23 Thyroid Disorders 231Elizabeth O. Buschur and Stephen F. Thung 24 Hepatitis in Pregnancy 241Andrew Myers, Asa Oxner, John Sinnott, and Christian Brechot 25 Asthma 253Michael Schatz 26 Epilepsy 263Thomas McElrath 27 Chronic Hypertension 273Michal Fishel Bartal and Baha M. Sibai 28 Cytomegalovirus, Genital Herpes, Rubella, and Toxoplasmosis 285Kerry E. Drury and Brenna L. Hughes 29 Syphilis 293Emily H. Adhikari 30 Vector‐Borne Diseases in Pregnancy: Zika, West Nile, and Chagas Disease 301Karin Nielsen‐Saines and Tara Kerin 31 Influenza 317Amanda C. Zofkie and Vanessa Rogers 32 Malaria 323Blair J. Wylie 33 Human Immunodeficiency Virus Infection 333Emily H. Adhikari 34 Parvovirus B19 343Kathy C. Matthews, Emilie L. Vander Haar, and Laura E. Riley 35 Group B Streptococcus 351Caitlin A. MacGregor, and Mara J. Dinsmoor 36 Biliary, Liver, and Pancreatic Disease 361Vic Velanovich, Elizabeth Hoover, and Stephanie Ros Part 4 Obstetric Problems 37 Cervical Insufficiency 375Rupsa C. Boelig and Vincenzo Berghella 38 Nausea and Vomiting 387Jared T. Roeckner and Haywood L. Brown 39 Fetal Death and Stillbirth 397Alexander M. Saucedo and Robert M. Silver 40 Abnormal Amniotic Fluid Volume 407Christina M. Ackerman, Thomas R. Moore, and Heather S. Lipkind 41 Fetal Growth Restriction 421Jodi S. Dashe and Anne M. Ambia 42 Rh and Other Blood Group Alloimmunizations 431Kenneth J. Moise Jr 43 Preterm Labor 443Hyagriv N. Simhan 44 Prevention of Preterm Birth 449Anna King and Sarah J.E. Stock 45 Premature Rupture of the Membranes 461Brian M. Mercer 46 Indicated Late‐Preterm and Early‐Term Deliveries 475Catherine Y. Spong 47 Chorioamnionitis 481Catalin S. Buhimschi and Irina A. Buhimschi 48 Third‐Trimester Bleeding 493Ilina D. Pluym and Christina S. Han 49 Amniotic Fluid Embolism 507Irene A. Stafford and Michael A. Belfort 50 Preeclampsia 517Michal Fishel Bartal and Baha M. Sibai Part 5 Labor and Delivery 51 Elective Induction of Labor 531Rachel G. Sinkey 52 Electronic Fetal Heart Rate Monitoring 539David A. Miller 53 Breech Delivery 555G. Justus Hofmeyr, and Mercy‐Nkuba Nassali 54 Vaginal Birth After Cesarean 563James R. Scott 55 Placenta Accreta Spectrum 571Robert M. Silver and Deirdre J. Lyell 56 Shoulder Dystocia 581George A. Macones and Robert B. Gherman 57 Twins, Triplets, and Beyond 587Mary E. D’Alton 58 Postpartum Hemorrhage 601David B. Nelson Appendix A: Evaluation of Fetal Health and Defects 613Lynn L. Simpson Index 629
£78.80
John Wiley and Sons Ltd How to Succeed in Medical Research
Book SynopsisHow to Succeed in Medical Research is a practical resource for medical students and junior doctors across all specialties. Designed for busy readers seeking to distinguish themselves in a highly competitive environment, this concise yet comprehensive guide provides step-by-step advice on selecting a project, finding a mentor, conducting a study, analysing results, publishing a paper, communicating findings, and much more. Presented in an accessible and conversational style, 14 succinct chapters walk readers through the essential stages of their research journey, from the initial steps to getting involved in research as a medical student, to effectively balancing clinical work, scientific research, and other academic pursuits early in your career as a healthcare professional. The book is packed with real-world case studies and expert tips to help readers apply the content directly in their own studies and careers. Straightforward and easy-to-use, this valuable guide:Table of ContentsForeword ix Preface xi About the Companion Website xiii Chapter 1 How to get involved in research 1 1.1 Why do research? 1 1.2 What can I become involved in? 2 1.3 Different types of research 2 1.4 Clinical vs laboratory 8 1.5 Getting ideas for research 8 References 9 Chapter 2 Conducting a study 11 2.1 How to find a research project 11 2.2 How to approach a mentor 14 2.3 Planning your study 17 2.4 Data collection 25 Chapter 3 Literature review and critical appraisal 27 3.1 Literature review 27 3.2 Search terms 28 3.3 Where to search 29 3.4 How to search 30 3.5 Critical appraisal 30 Chapter 4 Ethics and the ethical application 35 4.1 What is medical ethics and why is it important? 35 4.2 Main ethical considerations in medical research 35 4.3 Practical ethical applications 38 4.4 Dealing with conflicts in ethics 39 4.5 Ethical applications 40 Chapter 5 Analysing your data 42 5.1 What I need to know and how to find it 42 5.2 Variables 44 5.3 Analysis of categorical and continuous variables in two groups 47 5.4 Sensitivity and specificity 48 5.5 Positive predictive value and negative predictive value 50 5.6 Receiver operating characteristic curves 51 5.7 Logistic regression analysis 53 5.8 Other types of analysis 54 5.9 How to present your results 55 5.10 Conclusion 57 References 57 Chapter 6 Conferences and presentations: the next step in the research journey 58 6.1 Types of conferences 58 6.2 Prices and prizes 59 6.3 Abstract submission 60 6.4 Title 60 6.5 Introduction 60 6.6 Methods 60 6.7 Results 60 6.8 Conclusion 61 6.9 Poster presentation 63 6.10 Podium presentation 64 Chapter 7 Writing a paper 66 7.1 Title 66 7.2 Abstract 67 7.3 Introduction 68 7.4 Methods 69 7.5 Results 71 7.6 Discussion 72 7.7 Conclusion 73 7.8 References 74 7.9 Sending to seniors for review 74 Reference 75 Chapter 8 How to get published 76 8.1 Which journal? 76 8.2 Authorship 78 8.3 Getting your paper ready for the journal 79 8.4 Dealing with reviewer comments 80 8.5 Dealing with rejection 84 References 85 Chapter 9 Writing a case report 86 9.1 How to begin 86 9.2 Preparing to write the case report 88 9.3 Writing the case report 90 References 94 Chapter 10 Basic laboratory research 95 10.1 Introduction to laboratory research and translational research 95 10.2 Basic research versus clinical research 96 10.3 Laboratory hierarchy 97 10.4 Day to day of working in the lab 98 10.5 How to choose your lab 101 Chapter 11 Expanding your horizons in research 103 11.1 Research elective 103 11.2 Intercalated research degree 104 11.3 Postgraduate diplomas/certificates 105 11.4 Postgraduate degree 106 Chapter 12 Teaching 109 12.1 How to get involved in teaching 109 12.2 Teaching as an undergraduate student 110 12.3 Teaching as a postgraduate student 111 12.4 Teaching at work 112 12.5 Planning a lesson 115 12.6 Getting the most out of your teaching 116 12.7 Running a teaching course 118 12.8 How to set up a novel teaching course 118 12.9 How to run an established course 121 Chapter 13 Conducting an audit 122 13.1 What is clinical audit? 122 13.2 Conducting an audit 123 Chapter 14 Portfolio/CV 131 14.1 Keeping a portfolio 131 14.2 Curriculum vitae (CV) 135 Chapter 15 Maintaining a good balance 137 15.1 Stress and burnout 138 15.2 Improving your mindset to promote resilience 141 15.3 Other methods for resilience 142 15.4 Practical tips 144 References 145 Index 147
£28.45
John Wiley and Sons Ltd Atlas of Clinical Dermatopathology
Book SynopsisDifferential diagnosis is at its most accurate and efficient when clinical presentation and histopathological features are considered in correlation with one another. With that being so, the expert team behind this innovative atlas has integrated both perspectives to provide all those working in dermatologic healthcare with a complete guide to infectious and parasitic dermatoses in their many forms. More than 600 high-quality images demonstrate the common presentation of a wide range of bacterial, viral, and fungal infections, as well those of parasitic conditions of various kinds. Accompanying these are direct and easily understood descriptions of key features and diagnostic clues, making this new text an essential quick-reference tool for trainees and practicing clinicians alike. The Atlas of Clinical Dermatopathology: Infectious and Parasitic Dermatoses includes: A straightforward, pattern-based approach to dermatologic diagnosis Full-color illTable of ContentsForeword xi Acknowledgments xiii 1 Bacterial Infections 1 1.1 Staphylococcal and Streptococcal Infections 2 1.1.1 Impetigo Contagiosa 2 1.1.2 Ostiofolliculitis (Bockardt) 4 1.1.3 Pseudomonas (Gram‐Negative) Folliculitis (Whirlpool/Hot Tub Dermatitis) 5 1.1.4 Perianal Streptococcal Dermatitis 6 1.1.5 Differential Diagnosis: Acne Papulopustulosa 7 1.1.6 Differential Diagnosis: Pseudofolliculitis Barbae 8 1.1.7 Ecthyma Gangrenosum 8 1.1.8 Abscess 10 1.1.9 Furuncle 11 1.1.10 Carbuncle 12 1.1.11 Erysipelas (Cellulitis) 13 1.1.12 Phlegmon 15 1.1.13 Necrotizing Fasciitis (Streptococcal Gangrene)° 17 1.1.14 Hidradenitis Suppurativa (Acne Inversa) 17 1.2 Other Bacterial Infections: Corynebacteria 18 1.2.1 Erythrasma 18 1.2.2 Pitted Keratolysis (Keratoma Sulcatum) 19 1.2.3 Trichobacteriosis (Trichomycosis) Palmellina 20 1.2.4 Erysipeloid 21 1.2.5 Anthrax 22 1.2.6 Nocardiosis 23 1.2.7 Rhinoscleroma 24 1.3 Rochalimaea/Bartonellae 25 1.3.1 Bacillary Angiomatosis and Cat Scratch Disease 25 1.3.2 Verruga Peruana 27 1.3.3 Differential Diagnosis: Pyogenic Granuloma (Lobular Capillary Hemangioma; Botryomycosis) 28 1.4 Mycobacterial Infections 29 1.4.1 Tuberculosis Cutis 29 1.4.1.1 Primary Tuberculosis of the Skin 30 1.4.1.2 BCG Vaccination Granuloma 30 1.4.1.3 Differential Diagnosis: Lupus Miliaris Disseminatus Faciei (LMDF) 31 1.4.1.4 Lupus Vulgaris (LV) 32 1.4.1.5 Variant: Tuberculosis (Lupus) Cutis Verrucosa 34 1.4.1.6 Variant: Tuberculosis Cutis Colliquativa (Scrofuloderma) 35 1.4.1.7 Lichen Scrofulosorum (Tuberculosis Cutis Lichenoides) 36 1.4.1.8 Papulonecrotic Tuberculid 37 1.4.1.9 Erythema Induratum Bazin 38 1.4.2 Atypical Mycobacteriosis: Fish Tank (Swimming Pool) Granuloma 39 1.4.3 Leprosy (Hansen Disease) 40 1.4.3.1 Tuberculoid Leprosy 41 1.4.3.2 Borderline Leprosy 42 1.4.3.3 Lepromatous Leprosy 43 1.4.3.4 Variant: Histoid Lepromatous 45 1.4.3.5 Variant: Erythema Nodosum Leprosum 46 1.4.4 Buruli Ulcer 47 1.5 Actinomycosis 48 1.6 Borrelia Infections (Lyme Disease) 49 1.6.1 Variant: Erythema (Chronicum) Migrans (ECM) (Stage I) 50 1.6.2 Variant: Lymphadenosis Cutis Benigna (Pseudolymphoma, Lymphocytoma Cutis) (Stage I) 52 1.6.3 Variant: Morphea/Scleroderma‐Like Lesions (Stage II) 55 1.6.4 Variant: Acrodermatitis Chronica Atrophicans (Stage III) 56 1.6.5 Variant: Juxta‐Articular Fibrous Nodules in Acrodermatitis Chronica Atrophicans (Stage III) 58 1.6.6 Differential Diagnosis: Actinic Reticuloid° 59 1.7 Venereal Diseases 59 1.7.1 Gonorrhea 59 1.7.2 Syphilis, Chancre 60 1.7.2.1 Stage I 60 1.7.2.2 Stage II 61 1.7.2.3 Stage III° 62 1.7.3 Ulcus Molle (Chancroid) 63 1.7.4 Granuloma Inguinale (Donovanosis; Granuloma Venereum) 63 1.7.5 Lymphogranuloma Inguinale (Lymphogranuloma Venereum; Duran-Nicolas–Favre Disease) 64 1.8 Rickettsial Infections 65 1.9 Dermatoses Associated with Bacterial Infections 66 1.9.1 Staphylococcal Scalded Skin Syndrome (SSSS) 66 1.9.2 Differential Diagnosis: Toxic Epidermal Necrolysis (TEN) 67 1.10 Dermatoses Mimicking Bacterial Infections 68 1.10.1 Pyoderma Gangrenosum 68 1.10.2 Infantile Acropustulosis 70 1.10.3 Acute Generalized Exanthematous Pustulosis (AGEP) 71 1.10.4 Psoriasis Pustulosa 72 1.10.5 Localized Neutrophilic Eccrine Hidradenitis Associated with Mitoxantrone Treatment 73 1.10.6 Erosive Pustular Dermatitis (Pustular Ulcerative Dermatosis) of the Scalp 74 2 Fungal Infections 77 2.1 Superficial Cutaneous Fungal Infections 78 2.1.1 Variants: Tinea Corporis; Tinea Faciei 79 2.1.2 Variants: Tinea Barbae; Tinea Capitis (Trichophytia) 80 2.1.3 Granuloma Trichophyticum (Majocchi’s Granuloma) 82 2.1.4 Candidiasis (Moniliasis) 83 2.1.5 Candida Tropicalis and Candida Lipolytica 85 2.1.6 Pityriasis (Tinea) Versicolor 86 2.1.7 Variant: Malassezia (Pityrosporum) Folliculitis 87 2.1.8 Differential Diagnosis: Seborrheic Dermatitis 88 2.1.9 Tinea Nigra 89 2.1.10 Piedra (Trichomycosis Nodosa Alba and Nigra)° 90 2.2 Subcutaneous Mycoses 90 2.2.1 Sporotrichosis 90 2.2.2 Mycetoma (Madura Foot) 91 2.2.3 Chromo(blasto)mycosis (Dermatitis Verrucosa) 92 2.3 Systemic Mycoses (Deep Fungal Infections) 93 2.3.1 Cryptococcosis (Torulosis, European Blastomycosis) 94 2.3.2 North American Blastomycosis (Blastomycosis, Chicago Disease) 96 2.3.3 Lobomycosis (Lobo Disease, Keloidal Blastomycosis, Blastomycoid Granuloma) 98 2.3.4 Histoplasmosis 99 2.3.5 Coccidioidomycosis (Desert or Valley Fever, San Joaquin Fever) 100 2.3.6 Paracoccidioidomycosis (South American Blastomycosis) 101 2.3.7 Emmonsiosis 102 2.4 Opportunistic Fungal Infections 103 2.4.1 Aspergillosis (Alternaria) 103 2.4.2 Zygomycosis (Mucormycosis; Phycomycosis) 104 2.4.3 Hyalohyphomycosis 105 2.4.4 Phaeohyphomycosis 106 2.4.5 Protothecosis, Cutaneous 107 3 Viral Infections 109 3.1 Herpes Viruses 110 3.1.1 Herpes Simplex (HSV‐1, HSV‐2) 110 3.1.2 Varizella/Zoster Virus (VZV/HHV-3) 111 3.1.2.1 Varicella (Chickenpox) 112 3.1.2.2 Herpes Zoster (Shingles) 113 3.1.2.3 Special Feature: Necrotizing (Herpes) Zoster Folliculitis 115 3.1.2.4 Special Feature: Zoster‐Associated Vasculitis 116 3.1.2.5 Postherpetic Cutaneous Reactions° 117 3.1.3 Burkitt Lymphoma; Epstein‐Barr Virus (HHV-4; EBV) 117 3.1.4 Hairy Leukoplakia (HHV-4; Epstein‐Barr Virus; EBV) 118 3.1.5 Cytomegalovirus (CMV; HHV-5) 119 3.1.6 Exanthema Subitum (HHV-6) (Roseola Infantum, 6th Disease) 120 3.1.7 Pityriasis Rosea (HHV-7) 121 3.1.8 AIDS‐Kaposi Sarcoma (HHV-8) 122 3.1.9 Multicentric Castleman’s Disease (HHV-8) 127 3.2 Human Papilloma Virus (HPV) 128 3.2.1 Verruca Vulgaris 129 3.2.2 Variant: Verrucae Planae 132 3.2.3 Variant: Condylomata Acuminata 133 3.2.4 Differential Diagnosis: Acrokeratosis Verruciformis (Hopf) 134 3.2.5 Bowenoid Papulosis 135 3.2.6 Epidermodysplasia Verruciformis (Lewandowsky–Lutz); Verrucosis Generalisata 136 3.3 Viral Exanthema 137 3.3.1 Measles 138 3.4 Parvovirus Infections and Coxsackievirus Infections 139 3.4.1 Erythema Infectiosum; (Slapped Cheek Disease; Fifth Disease) 139 3.4.2 Papular Purpuric Glovesand‐Socks Syndrome 140 3.4.3 Hand‐Foot‐and‐Mouth Disease (Coxsackie Virus) 141 3.5 Polyoma Virus Infections 142 3.5.1 Trichodysplasia Spinulosa 142 3.5.2 Merkel Cell Carcinoma (Primary Neuroendocrine Carcinoma of the Skin; Trabecular Carcinoma of Toker) 144 3.6 Poxviruses 146 3.6.1 Orthopox Virus Infections 146 3.6.1.1 Cowpox (Catpox) 147 3.6.1.2 Vaccinia Inoculata 148 3.6.1.3 Smallpox (Variola Vera) 148 3.6.2 Parapox Virus Infections 149 3.6.2.1 Ecthyma Contagiosum (Orf) 149 3.6.2.2 Variant: Milker’s Nodule 150 3.6.2.3 Molluscum Contagiosum 151 3.7 Other Skin Diseases with Suspected Viral Association 152 3.7.1 Asymmetric Periflexural Exanthema of Childhood 152 3.7.2 Eruptive Pseudoangiomatosis 153 3.7.3 Gianotti–Crosti Syndrome 154 3.7.4 Pityriasis Lichenoides 155 4 Parasitoses 159 4.1 Protozoan Diseases 160 4.1.1 Leishmaniasis 160 4.1.2 Variant: Leishmaniasis Mexicana 162 4.1.3 Amebiasis: Entamoeba Histolytica 163 4.1.4 Rhinosporidiosis 164 4.2 Arthropod: Arachnids 165 4.2.1 Mites 165 4.2.1.1 Demodex Folliculorum 166 4.2.1.2 Scabies 167 4.2.1.3 Variant: Scabies Crustosa 168 4.2.1.4 Trombidiosis (Harvest Mites; Chigger Itch) 169 4.2.2 Spiders° 169 4.2.3 Ticks° 170 4.2.4 Insects 170 4.2.5 Tungiasis (Sand Flea) 171 5 Helminthic Infections (Parasitic Worms) 173 5.1 Larva Migrans (Plumber’s Itch; Creeping Eruption) 174 5.2 Filariasis 175 5.3 Onchocerciasis (River Blindness) 176 5.4 Cysticercosis 177 5.5 Sparganosis 177 5.6 Schistosomiasis (Bilharziasis) 178 5.7 Cercarial Dermatitis (Swimmer’s Itch) 179 5.8 Annelida (Ringed Worms; Segmented Worms)° 180 5.9 Hirudinea (Leeches) 180 6 Sepsis 181 6.1 Septic Vasculitis 182 6.2 Bacterial Sepsis 185 6.2.1 Gonococcal Sepsis 185 6.3 Fungal Sepsis 186 6.3.1 Variant: Penicillium Marinum Sepsis 186 6.3.2 Variant: Candida Sepsis 187 6.3.3 Variant: Aspergillus Sepsis 187 Index 189
£111.56
John Wiley and Sons Ltd Fundamentals of Pharmacology for Midwives
Book SynopsisFundamentals of Pharmacology for Midwives provides the reader with a thorough understanding of the essentials of pharmacology associated with childbearing women, and improving safety and care outcomes whilst ensuring the comfort of the mother. It is essential that midwifery students have a knowledge and an understanding of pharmacology, along with an ability to recognise the positive and opposing effects of medicines from conception to birthincluding allergies and drug sensitivities, side effects and adverse reactions, contraindications and errors in prescribing, and more. Written with the latest NMC Standards of Proficiency for Registered Midwives (NMC 2019) in mindEach chapter includes test your prior knowledge' questions, learning outcomes, and skills in practice boxes that encourage the reader to apply the theory to everyday practiceIncludes companion website for the book at www.wiley.com/go/pharmacologyformidwives that contains multiple-choice questions, powerpoint slides, glossaries, chapter references and other self-test material designed to enhance learning Fundamentals of Pharmacology for Midwives provides a useful reference for those studying to be midwives and support clinicians in the field, helping them become safe and accountable practitioners offering competent and confident women-centred care. All content reviewed by students for students. If you would like to be one of our student reviewers, go to www.reviewnursingbooks.com to find out more. To receive automatic updates on Wiley books and journals, join our email list. Sign up today at www.wiley.com/emailTable of ContentsContributors xix Preface xxi Acknowledgements xxiii How to Use Your Textbook and the Companion Website xiii Part I Essentials of pharmacology 1 Chapter 1 Introduction to pharmacology 3 Jenny Brewster Aim 3 Introduction 3 Pharmacology 4 Nursing and Midwifery Council (NMC) 4 Medicines optimisation 6 Embryology 6 The use of medicines in pregnancy 7 Pre- existing conditions 9 Occupational exposure 10 Drugs used in labour 10 Breast feeding 11 Conclusion 12 Glossary 12 Test yourself 12 References 12 Further reading 14 Chapter 2 How to use pharmaceutical and prescribing reference guides 15 Kirsty Fishburn and Andrea Hilton Aim 15 Introduction 16 British National Formulary and British National Formulary for Children 16 Drug tariff 20 Electronic medicines compendium (eMC) 20 Medicines and Healthcare products Regulatory Agency 21 National Institute for Health and Care Excellence 22 UK teratology information service 23 Conclusion 24 Glossary 24 Test yourself 25 References 25 Chapter 3 Legal and ethical issues 27 Hema Turner Aim 27 Introduction 27 The law 28 Ethical principles 32 Consent for treatment: adults 34 Research 37 Conclusion 38 Test yourself 39 References 39 Chapter 4 Medicines management 42 Rebecca Murray Aim 42 Introduction 42 Medicines management and optimisation 43 Medicines regulations 44 The ‘rights’ of medicines administration 45 Medication errors 48 Self- administration of medicines 48 Storage and disposal of medicines 48 Student midwives 49 Conclusion 49 Glossary 50 Test yourself 50 References 50 Further reading 51 Part 2 Introduction to pharmacology 53 Chapter 5 Pharmacodynamics and pharmacokinetics 55 Barry Hill and Claire Leader Aim 55 Introduction 55 Regulatory bodies 56 Teratogenesis and Fetotoxicity 56 Pharmacokinetics 57 Pharmacodynamics 67 Conclusion 75 Test yourself 75 References 75 Chapter 6 Formulations 77 Sinéad McKee and Cathy Hamilton Aim 77 Introduction 77 Oral route of administration 78 Topical route of administration 81 Transdermal route of administration 83 Inhalation route of administration 85 Injection route of administration 86 Conclusion 88 Glossary 89 Test yourself 89 References 89 Further reading 91 Chapter 7 Adverse drug reaction 92 Cathy Hamilton Aim 92 Introduction 92 Classification of ADR 93 Recognising an ADR 94 Predisposing factors for ADRs 94 Physical signs and symptoms of ADR 96 Management of a suspected ADR 96 Reporting ADRs 98 Conclusion 100 Glossary 101 Test yourself 101 References 101 Chapter 8 Analgesics 103 Iñaki Mansilla Aim 103 Introduction 103 Physiological changes in pregnancy and the puerperium that may require pain management 104 Pain transmission during pregnancy, labour and puerperium 105 Pain management 106 Non- pharmacological approach to analgesia 113 Pharmacological approach to analgesia 113 Pharmacological analgesia provided by an anaesthetist and monitored by midwives 115 Postnatal analgesia 116 Conclusion 117 Glossary 117 Test yourself 117 References 117 Chapter 9 Antibiotics and antibacterials 121 Amanda Waterman Aim 121 Introduction 121 Terminology and differences between micro- organisms 122 Antibiotic resistance and the global impact 123 Antibacterial stewardship programme 123 Bacteria 124 Prescribing 133 Conclusion 138 Glossary 139 Test yourself 139 References 140 Further reading 143 Part 3 Medications used during pregnancy and childbirth 145 Chapter 10 Medications used in labour 147 Chin Swain Aim 147 Introduction 147 Uterotonic drugs 148 Epidural 156 Spinal anaesthesia 158 Documentation 159 Conclusion 159 Find out more 159 Glossary 160 Test yourself 161 References 161 Chapter 11 Medications and the cardiovascular system 163 Carl Clare Aim 163 Introduction 163 Cardiac disease and pregnancy 164 Antiarrhythmic drugs 165 Antihypertensive drugs 172 Fibrinolytics 173 Cardiomyopathy 175 Hyperlipidaemia 178 Breast feeding 178 Conclusion 178 Find out more 178 Glossary 179 Test yourself 179 References 180 Further reading 180 Chapter 12 Medications and the renal system 181 Sam Bassett Aim 181 Introduction 182 Anatomy and physiology of the renal tract 182 Physiological changes to the renal system during pregnancy 183 Common renal conditions in pregnancy 184 Specific conditions and their management 191 Conclusion 199 Find out more 199 Glossary 199 Test yourself 200 References 200 Chapter 13 Medications and diabetes 202 Carl Clare and Celia Wildeman Aim 202 Introduction 202 Physiology 203 Pathophysiology 205 Signs and symptoms 205 Diagnosis and investigations 206 Treatment of diabetes 208 Care of the woman during pregnancy in the presence of pre- existing diabetes 212 Blood glucose monitoring in diabetes 214 Diabetic emergencies 217 Diabetes and birth 218 Conclusion 219 Find out more 219 Glossary 219 Test yourself 220 References 220 Further reading 221 Chapter 14 Medications and respiration 222 Helen McIntyre Aim 222 Introduction 222 Asthma 223 Chronic obstructive pulmonary disease 225 Tuberculosis 229 Influenza 232 Pneumonia and COVID- 19 232 Pulmonary embolism 234 Cystic fibrosis 235 Human immunodeficiency virus 236 Find out more 236 Glossary 236 Test yourself 237 References 237 Chapter 15 Medications and the gastrointestinal system 239 Debbie Gurney Aim 239 Introduction 239 Nausea and vomiting in pregnancy 240 Heartburn 243 Constipation 247 Irritable bowel syndrome 249 Diarrhoea 250 Anorectal conditions 250 Conclusion 252 Find out more 253 Glossary 253 Test yourself 254 References 254 Further reading 255 Chapter 16 Medications and nutritional supplementation 256 Cathy Ashwin Aim 256 Introduction 257 Assessing the needs of the woman 257 Folic acid 257 Iron 259 Vitamin D and calcium 262 Vitamin B12 262 Vitamin A 263 Vitamin B6 264 Vitamin E 264 Vitamin K 265 Zinc 266 Magnesium 266 Herbal and integrative supplementation and therapies 266 Factors affecting adequate vitamin and mineral intake during pregnancy 268 Conclusion 268 Find out more 268 Glossary 269 Test yourself 269 References 270 Further reading 271 Chapter 17 Medications and the nervous system 272 Cathy Hamilton Aim 272 Introduction 273 Headache and migraine 273 Epilepsy 275 Conclusion 284 Find out more 285 Glossary 285 Test yourself 285 References 285 Chapter 18 Medications and mental health 288 Emmanuel Ndisang Aim 288 Introduction 288 Medications and mental health presentations 289 Psychotropic medication in the perinatal period 292 Psychotropic medications and lactation 297 Conclusion 298 Glossary 299 Test yourself 299 References 299 Further reading 301 Chapter 19 Medications and the immune system 302 Janet G. Migliozzi and Cathy Hamilton Aim 302 Introduction 302 Immunity 303 Vaccines 304 Conclusion 314 Find out more 314 Glossary 315 Test yourself 315 References 316 Chapter 20 Medications and breast feeding 318 Deborah Sharp and Zoi Vardavaki Aim 318 Introduction 319 Transfer of medication in breast milk 319 Maternal diseases and medication in the breast- feeding mother 323 Over- the- counter medicines 326 Midwife’s role 326 Breast feeding and medications information 327 Conclusion 327 Find out more 327 Glossary 328 Test yourself 328 References 328 Further reading 329 Chapter 21 Medications and sexually transmitted infections 330 Celia Wildeman Aim 330 Introduction 331 Bacteria 331 Viruses 332 Parasites 332 Chlamydia trachomatis (chlamydia) 334 Gonorrhoea 338 Syphilis 341 Hepatitis B virus 342 Human papillomavirus 343 Human immunodeficiency virus (HIV) 344 Trichomonas vaginalis (TV) 345 Conclusion 346 Glossary 346 Test yourself 347 References 347 Further reading 348 Chapter 22 Medications and recreational drug use 349 Laura Abbott and Karen Mills Aim 349 Introduction 349 Role of midwives working with women who use drugs 350 Drugs of misuse 350 Absorption, distribution, metabolism and excretion (ADME) of drugs 355 Understanding the role drugs play in the lives of women 355 Drug use, pregnancy and risks 357 Breast feeding and drug use 358 Conclusion 359 Find out more 360 Glossary 360 Test yourself 360 References 361 Further reading 363 Chapter 23 Medications used in emergency midwifery situations 364 Jayne E. Marshall Aim 364 Principles of managing maternity emergencies 365 Communication 365 Professional responsibility in emergency situations 367 Maternal collapse 368 Thrombosis and thromboembolism 371 Drug toxicity/overdose 373 Major haemorrhage/hypovolaemia 374 Pre- eclampsia and eclampsia 379 Sepsis 383 Cardiac arrest 383 Perimortem caesarean section (resuscitative hysterotomy) 384 Conclusion 387 Find out more 387 Glossary 387 Test yourself 387 References 388 Further reading 389 Chapter 24 Medications used in contraception 390 Emma Dawson- Goodey Aim 390 Introduction 390 Pharmacokinetic and pharmacodynamic interactions 392 Combined hormonal contraception 393 Progesterone- oral pill 396 Progesterone injection 397 Progesterone implant 398 Intrauterine contraceptive (IUC) 399 Emergency contraception 400 Conclusion 401 Find out more 402 Glossary 402 Test yourself 403 References 403 Further reading 403 Index 405
£35.10
Wiley-Blackwell Putting Pharmacokinetics and Pharmacodynamics to
Book Synopsis
£118.70
John Wiley & Sons Inc Poisonous Plants and Phytochemicals in Drug
Book SynopsisFocusing on phytochemicals and their potential for drug discovery, this book offers a comprehensive resource on poisonous plants and their applications in chemistry and in pharmacology. Provides a comprehensive resource on phytotoxins, covering historical perspectives, modern applications, and their potential in drug discoveryCovers the mechanisms, benefits, risks and management protocols of phytotoxins in a scientific laboratory and the usefulness in drug discoveryPresents chapters in a carefully designed, clear order, making it an ideal resource for the academic researcher or the industry professional at any stage in their careerTable of ContentsList of Contributors xvii List of Figures xxi List of Tables xxiii Preface xxv Editors xxvii 1 Historical Use of Toxic Plants 1Godwin Anywar 1.1 Introduction to Toxic Plants 1 1.2 Poisonous Plants as Sources of Traditional and Modern Medicines 2 1.3 Toxic Plants and Justice 4 1.3.1 Toxic Plants in Capital Punishment 4 1.3.2 Trial by Ordeal 4 1.4 Toxic Plants in Poisoned Weapons 6 1.4.1 Arrow Poisons 6 1.5 Plant Fishing Poisons/Piscicides/Ichthyotoxins 6 1.6 Poisonous Plants as Food 7 1.7 Poisonous Plants as Biopesticides 9 1.8 Toxic Psychoactive Plants for Recreational and Religious Purposes 9 1.9 Poisonous Plants in Warfare and Bioterrorism 10 1.10 Poisonous Plants as Carcinogens and Teratogens 11 1.11 Conclusion 12 References 12 2 Classification of Phytotoxins and their Mechanisms of Action 19Andrew G. Mtewa, Chukwuebuka Egbuna, Kennedy J. Ngwira, Fanuel Lampiao, Umang Shah, and Thokozani Kachulu Mtewa 2.1 Introduction 20 2.1.1 Endophytic Phytotoxins 20 2.1.2 Secondary Metabolites 21 2.2 Possible Categorization 21 2.2.1 Biological Characteristics 21 2.2.2 Chemical Characteristics 22 2.3 Currently Available Classification Tools 24 2.4 Role of Phytotoxin Classification 25 2.4.1 Drug Discovery 25 2.4.2 Environmental Monitoring 25 2.4.3 Phytotoxins, Aquatic Life, and Water Quality 26 2.4.4 Air Contamination 26 2.4.5 Food Contamination 26 2.4.6 Security and Safety Services 27 2.4.7 Agricultural 27 2.5 Brief Mechanisms of Action 27 2.6 Conclusion 28 References 28 3 Poisonous Plants as Sources of Anticancer and Other Drugs 31Félicien Mushagalusa Kasali, Andrew G. Mtewa, and Gaétan Tabakam 3.1 Introduction 31 3.2 Poisonous Plants in the Treatment of Cancer and Other Diseases 32 3.3 Poisonous Plant-Based Anticancer Drugs that are on the Market 33 3.4 Poisonous Plant-Based Drugs Against Other Diseases that are on the Market 33 3.5 Conclusion 33 References 75 4 Drugs in Clinical Practice from Toxic Plants and Phytochemicals 79Tadele Mekuriya Yadesa, Patrick Engeu Ogwang, and Casim Umba Tolo 4.1 Introduction 80 4.2 Drugs in Clinical Practice from Toxic Plants 81 4.2.1 Curare 81 4.2.2 Drugs Acting on the Central Nervous System 81 4.2.2.1 Morphine 81 4.2.2.2 Cocaine 82 4.2.2.3 Ergot Alkaloids 83 4.2.3 Atropine, Scopolamine, and Hyoscyamine 84 4.2.4 Physostigmine and Other Acetylcholinesterase Inhibitors 85 4.2.5 Antitumor Agents 85 4.2.5.1 Podophyllotoxin and Etoposide 85 4.2.5.2 Taxanes 86 4.2.5.3 Vincristine and Vinblastine 87 4.2.6 Other Drugs 88 4.2.6.1 Cardiac Glycosides 88 4.2.6.2 Colchicine 89 4.2.6.3 Coumarins 89 4.2.6.4 Nicotine and the Neonicotinoids 90 References 90 5 Toxicology and Health Benefits of Plant Alkaloids 95Ibrahim Chikowe, Andrew G. Mtewa, and Duncan C. Sesaazi 5.1 Introduction 95 5.2 Pharmacological Properties of Alkaloids 97 5.3 Toxicological Properties of Alkaloids 100 5.4 Acute and Chronic Toxicities 100 5.4.1 Genotoxicity and Tumorigenicity 101 5.4.2 Lung Toxicity, Neurotoxicity, and Teratogenicity 102 5.5 Factors that Influence the Toxicological Profile of Alkaloids 102 5.6 Conclusion 103 References 103 6 Chemical and Pharmacological Mechanisms of Plant-Derived Neurotoxins 109Amanjot Annu, Reuben S. Maghembe, Andrew G. Mtewa, and G.M. Narasimha Rao 6.1 Introduction 110 6.2 Nerve Agents 110 6.3 Chemical Mechanisms of Neurotoxicity Induced by Organophosphate Nerve Agents 111 6.4 Mustards 112 6.4.1 Effect of HD on Skin 113 6.4.2 Effect of HD on Other Organs 113 6.4.3 The Activation of HD 114 6.4.4 Mechanism of Action 115 6.5 Plant Natural Neurotoxins 116 6.6 Plant Glycosides 118 6.7 Conclusion 119 References 119 7 Phytosedatives for Drug Discovery 123Shahira M. Ezzat, Ahmed Zayed, and Mohamed A. Salem 7.1 Introduction 123 7.2 Treatment of Neuropsychological Disorders: The Current Scenario 124 7.3 Phytosedatives: Desirable Alternatives to Synthesized Drugs 125 7.4 Different Classes of Phytosedatives 125 7.4.1 Flavonoids 126 7.4.2 Alkaloids 128 7.4.3 Essential Oils 129 7.4.4 Other Classes of Phytosedatives 130 7.5 Plants with Reported Sedative Actions 130 7.6 Conclusion 152 References 152 8 Mushroom Species and Classification: Bioactives in Poisonous and Edible Mushrooms 163Sadia Zafar, Farhat Jabeen, Muhammad Akram, Zarfishan Riaz, and Naveed Munir 8.1 Introduction 163 8.2 Classification of Mushrooms 164 8.2.1 Edible Mushrooms 165 8.2.2 Non-Edible Mushrooms 165 8.3 Bioactive Agents in Mushroom Species 165 8.4 Bioactive Agents in Non-Edible Mushroom Species 166 8.4.1 Polysaccharides 166 8.4.2 Glucans 166 8.4.3 Polysaccharide–Protein Complexes 174 8.4.4 Terpenes 174 8.4.5 Phenolic Compounds 175 8.4.6 Peptides and Proteins 176 8.5 Other Bioactive Compounds of Mushroom Species 176 8.6 Conclusion 176 References 177 9 Toxicity Protocols for Natural Products in the Drug Development Process 189Tamirat Bekele Beressa, Amanjot Annu, and Andrew G. Mtewa 9.1 Introduction 190 9.2 In Vitro Toxicity Testing for Natural Products 190 9.2.1 Cell Culture Method for Toxicity Testing 191 9.2.2 Cell Culture for Acute Toxicology Testing 192 9.3 Methods Used for In Vitro Toxicity Studies 193 9.3.1 MTT Assay 193 9.3.2 Neutral Red Uptake Assay 193 9.3.3 Lactate Dehydrogenase Assay 194 9.4 In Vitro Models for Liver Toxicity 194 9.5 In Vitro Models for Nephrotoxicity Studies 194 9.6 In Vitro Model for Dermal Toxicity Testing 195 9.7 Mutagenicity Testing In Vitro 195 9.7.1 Bacterial Cell System 196 9.8 Reproductive and Teratogenicity Studies In Vitro 196 9.8.1 H295R Steroidogenesis Assay 197 9.8.2 Embryonic Stem Cell Test 197 9.8.3 Whole Rat Embryo Cultures 197 9.9 In Vivo Toxicity Testing of Natural Products 198 9.9.1 Acute Toxicity Testing 198 9.9.2 Subchronic Toxicity Testing 200 9.9.3 Chronic Toxicity Testing 201 9.9.4 Dermal and Ocular Toxicity 203 9.9.5 Toxicity Testing for Fertility and Reproduction 204 9.9.6 Combined Repeated Dose Toxicity Study with Reproduction/Developmental Testing 206 9.9.7 In Vivo Carcinogenicity Testing 207 9.10 Conclusion 208 References 208 10 Quality Control for the Safety of Natural Products 213Tadele Mekuriya Yadesa, Patrick Engeu Ogwang, and Casim Umba Tolo 10.1 Introduction 214 10.2 Quality Assurance of Herbal Products 215 10.3 Methods of Quality Control for Herbal Products 216 10.3.1 DNA-Based Technologies 216 10.3.2 Good Practice Guidelines 216 10.3.3 Chemoprofiling 217 10.3.4 Toxicology 217 10.3.5 Monographs and Pharmacopeias 217 10.3.6 Preclinical Evidence of Safety and Efficacy 217 10.3.7 Systems Biology 218 10.3.8 Animal Experimentation 218 10.3.9 Clinical Evidence of Safety and Efficacy 218 10.4 WHO Guidelines for Quality Standardization of Herbal Formulations 219 10.4.1 Quality Control of Crude Material 219 10.4.2 Identity of Plant Material 219 10.4.3 Safety Assessment and Documentation 220 10.5 Concept of Validation in Herbal Products 220 10.6 Challenges Related to Quality Control and Monitoring the Safety of Herbal Products 221 References 222 11 Secondary Metabolites and Toxins of Microbial Origin for the Treatment of Diseases 225Dharmandra Baria, Umang Shah, Chukwuebuka Egbuna, and Andrew G. Mtewa 11.1 Introduction 226 11.2 Antimicrobial Agents from Microbial Sources 227 11.3 Antifungal Agents from Microbial Sources 229 11.4 Anticancer Agents from Microbial Sources 230 11.5 Hypocholesterolemic Agents from Microbial Sources 235 11.6 Immunosuppressants from Microbial Sources 237 11.7 Enzyme Inhibitors from Microbial Sources 239 11.8 Antiparasitic Agents from Microbial Sources 240 11.9 Recent Advances in Drug Discovery from Microbial Sources 241 References 243 12 Development of Phyto-Antidotes Against Adverse Chemical Agents 249Roman Lysiuk, Petro Oliynyk, Halyna Antonyak, and Dmytro Voronenko 12.1 Introduction 249 12.2 Heavy Metals and their Effects on the Body 251 12.3 Detoxification Properties of Biologically Active Substances of Plant-Based Foods 253 12.3.1 Pectins 253 12.3.2 Phytin 254 12.3.3 Betalains 255 12.3.4 Phytochelatins 256 12.3.5 Ellagic Acid 257 12.3.6 Miscellaneous 258 12.4 Current State of Clinical Application of Phyto-Antidotes 259 12.5 Further Prospects in the Search for Promising Phyto-Antidotes 260 12.6 Conclusions 261 References 262 13 Nanoformulated Herbal Drug Delivery as Efficient Antidotes Against Systemic Poisons 269Prabir Kumar Kulabhusan, Shailaja Agrawal, Jaison Jeevanandam, and Michael K. Danquah 13.1 Introduction 269 13.2 Herbal Phytochemicals as Antidotes for Systemic Poisons 271 13.2.1 Herbal Phytochemicals as Antidotes for Heavy Metal Poisoning 272 13.2.2 Herbal Phytochemicals as Antidotes for Snake Venom Poisoning 275 13.3 Nanoformulated Herbal Phytochemicals as Antidotes 276 13.3.1 Inorganic Nanoparticles 278 13.3.2 Micelles and Liposomes 279 13.3.3 Polymeric Nanoparticles 281 13.4 Mechanism of Nanoformulated Herbal Phytochemicals against Systemic Poisoning 281 13.5 Future Perspectives 283 13.6 Conclusion 285 References 285 14 Phytochemical-Based Nanoparticles as Foes and Friends 295Charles Oluwaseun Adetunji, Oluwaseyi Olaniyan, Juliana Bunmi Adetunji, and Itoan Roli 14.1 Introduction 295 14.2 Phytochemicals Used in the Synthesis of Nanoparticles 297 14.3 Anti-Inflammatory Effects of Nanoparticles 297 14.4 Wound-Healing Effects of Nanoparticles 299 14.5 Antiparasitic, Antifungal, and Antibacterial Activities of Nanoparticles 300 14.6 Neuroprotective Effects of Nanoparticles 304 14.7 Cardioprotective Effects of Nanoparticles 307 14.8 Anticancer Effects of Nanoparticles 308 14.9 Advantages of Nanoparticles 311 14.10 Disadvantages of Nanoparticles 311 14.11 Conclusion and Future Directions 312 References 313 15 Application of Metabolomics in Emergency Phytochemical Poisoning and Remediation 323Mohamed A. Salem, Ahmed Zayed, and Shahira M. Ezzat 15.1 Introduction 324 15.2 Traditional Use of Medicinal Plants 325 15.3 Natural Products: Safety and Toxicity 328 15.3.1 Safety 328 15.3.2 Toxicity and Natural Killers 329 15.4 Biological Systems in Phytochemical Poisoning and Remediation 330 15.5 Metabolomics: An Important Functional Genomics Tool 332 15.5.1 Essential Components of a Metabolomics Workflow 333 15.5.2 Sample Preparation 334 15.5.3 Analytical Methods in Metabolomics 334 15.5.4 Metabolite Identification 335 15.5.5 Data Processing and Analysis 335 15.5.6 Pathway Analysis 335 15.6 Assessment of Toxicity of Herbal Medicines Using Metabolomics 335 15.7 Application of Metabolomics in Emergency Phytochemical Poisoning and Remediation 336 15.7.1 Hepatotoxicity of Triptolide 337 15.7.2 Hepatotoxicity of Noscapine 337 15.8 Conclusion 338 References 338 16 Methods for the Detection and Identification of Phytotoxins 349Senyo Botchie and Andrew G. Mtewa 16.1 Introduction 350 16.2 Phytotoxins 350 16.2.1 Importance of Toxins 351 16.3 Methods Generally Used for Phytotoxin Detection 352 16.3.1 Biological Method Review of Detecting Phytotoxins 352 16.3.2 Chemical and Microbiological Reagents 352 16.4 Protease Inhibition Detection Protocol 354 16.4.1 Exposure of the Protease Detection Plate to a Protease Inhibitor or Bacterial Growth (Step 1) 354 16.4.2 Exposure to a Protease-Containing Solution (Step 2) 355 16.4.3 Detecting Zones of Protease Inhibition (Step 3) 355 16.5 Isolation of Phytotoxins from Microorganisms 355 16.5.1 Detection of Phytotoxins Isolated from Fungi 356 16.5.2 Purification of the Extracted Phytotoxins 356 16.6 Conclusion 356 References 357 17 Categorization, Management, and Regulation of Potentially Weaponizable Toxic Plants 359Muhammad Akram and Rabia Zahid 17.1 Introduction 359 17.2 Management of Weaponized Natural Food Agents 360 17.3 Techniques Used for Extraction, Segregation, and Decontamination of Phytochemicals 361 17.3.1 Solvent-Based Extraction of Phenolic Compounds 361 17.3.2 Microwave-Associated Extraction 361 17.3.3 Ultrasound-Assisted Extraction 362 17.4 Techniques for Identification of Bioactive Compounds 362 17.4.1 Ultraviolet–Visible Spectroscopy 362 17.4.2 Infrared Spectroscopy 363 17.4.3 Nuclear Magnetic Resonance Spectroscopy 363 17.4.4 Mass Spectrometry 363 17.5 Types of Natural Phytotoxins 363 17.5.1 Aquatic Biotoxins 363 17.5.2 Glycosides 364 17.5.3 Other Common Phytotoxins 364 17.6 Conclusion 365 References 365 18 In Silico Modeling as a Tool to Predict and Characterize Plant Toxicity 367Charles Oluwaseun Adetunji, William Peter Mitembo, Chukwuebuka Egbuna, and G.M. Narasimha Rao 18.1 Introduction 368 18.2 Components of In Silico Toxicity Methods 368 18.2.1 Databases 369 18.2.2 Molecular Descriptors 369 18.2.3 Toxicity Models and Modeling Software 369 18.2.4 Simulation Packages 369 18.3 Modeling Methods 371 18.4 Structural Alerts/Rule Based 371 18.5 Statistical Structure-Based Activity Relationship Models 373 18.5.1 Read-Across 373 18.6 Conclusion 374 References 375 Index 379
£139.45
John Wiley and Sons Ltd Psychiatry Algorithms for Primary Care
Book SynopsisPsychiatry Algorithms for Primary Care is a practical, quick reference guide to psychiatric assessment and mental healthcare in general practice. Providing algorithms informed by evidence-based guidelines, this easy-to-use resource helps busy medical and healthcare professionals quickly assess mental health problems, make informed treatment decisions, and understand when referrals to specialist mental health services are appropriate. Drawing from their extensive experience in general practice and psychiatry, the authors provide clear and authoritative guidance on a wide range of common psychiatric disorders, complex scenarios, and special considerations. Unique visual management algorithms define assessment, diagnosis, investigations and management for each condition, including Bipolar Affective Disorder, Psychosis, Depression, Dementia, and Attention Deficit Hyperactivity Disorder. Up-to-date information on medication choices and counselling strategies is found throughout the text.Table of ContentsForeword ix Acknowledgements xi Author Profiles xii Part 1 Introduction 1 1 How to Use This book 3 2 History Taking in General Practice 5 3 The Rapid Mental State Examination 8 Part 2 Common Psychiatric Disorders 13 4 Generalised Anxiety Disorder (GAD) 15 5 Panic Disorder 19 6 Obsessive Compulsive Disorder (OCD) 22 7 Social Phobia 25 8 Post-Traumatic Stress Disorder (PTSD) 28 9 Depression 31 10 Bipolar Affective Disorder (BPAD) 35 11 Psychosis 39 12 Eating Disorders 43 13 Personality Disorders 46 14 Alcohol Use Disorder 50 15 Substance Use Disorder 54 16 Opiate Use Disorder 57 17 Adult Attention Deficit Hyperactivity Disorder (ADHD) 60 18 Autism Spectrum Disorder (ASD) 63 19 Delirium 65 20 Dementia 68 Part 3 Common Presentations in Primary Care 71 21 Fatigue 73 22 Insomnia 76 23 Medically Unexplained Symptoms 79 Part 4 Complex Scenarios 83 24 Suicide and Self Harm 85 25 Aggression 89 26 Referrals for Involuntary Care 91 Part 5 Special Considerations in Prescribing 95 27 Special Considerations: Older Adults 97 28 Special Considerations in Prescribing: Children and Adolescents 100 29 Special Considerations in Prescribing: People with Intellectual Disabilities 103 30 Special Considerations in Prescribing: Pregnancy and Breastfeeding 105 Part 6 Appendices 107 31 Commonly Prescribed Drugs 109 32 Physical Health in Patients with Severe Mental Illness 119 Part 7 Self-Assessment 123 33 Self-Assessment Cases 125 34 Self-Assessment Answers 138 Index 140
£35.10
John Wiley and Sons Ltd Discovering Precision Health
Book SynopsisTable of ContentsAbout the Authors ix Acknowledgments xi Introduction The Power of Precision Health 1 Chapter 1 The State of U.S. Health and Health Care Delivery 15 Chapter 2 There’s More to “Health” Than Health Care 33 Chapter 3 The Innovation and Disruption Powering Progress in Health 43 Chapter 4 Fundamental, Discovery‐Focused Research: The Foundation of Biomedical Breakthroughs 111 Chapter 5 Peering into the Future: Leveraging The Powers of Prediction to Help Prevent Illness 147 Chapter 6 Prevention as a Pathway to Health and Wellness 177 Chapter 7 Curing Disease with More Precise Medical Therapies 207 Conclusion Achieving Precision Health: The Opportunities—and Challenges—Ahead 237 Notes 243 Index 259
£28.76
John Wiley and Sons Ltd Cosmetic Dermatology Products and Procedures Thi
Book SynopsisIn the Third Edition ofCosmetic Dermatology: Products and Procedures, accomplished dermatologistDr.Zoe DianaDraelosdelivers the latest information on procedural innovations in the rapidly developing field of cosmetic dermatology. This new edition is structured to follow the typical patient's cosmetic routing, from everyday moisturizing to adornment and anti-aging techniques. It includes summary boxes at the start of each section to allow for quick reference in a clinical setting, over 300 full-colorimages illustrate procedures, and demonstrates the benefits of cosmetic products and techniques. Cosmetic Dermatologycombines the expertise of leaders in research, industry, surgery, and practice to introduce cutting edge concepts and outline the best techniques in the cosmeticfield. It addresses appearance issues affecting the skin, hair, and nails. The newedition offersa complete cosmetic regimen for the patients of any cosmetic dermatologist, whether hospital-based or in private practice. It also provides: A thorough introduction to basic concepts in dermatology, including skin physiology pertinent to cosmetic dermatology and the delivery of cosmeticactivesA comprehensive exploration of skin hygiene products, including cleansers, moisturizers, and personal careproductsPractical discussions of adornments, includingcoloredfacial cosmetics, eye cosmetics, camouflaging products, nail cosmetics, and haircosmeticsIn-depth examinations of anti-aging products and procedures, including cosmeceuticals, injectable anti-aging techniques, resurfacing techniques, and skin modulationtechniques Cosmetic Dermatologyis perfect for practicing and academic dermatologists, trainee dermatologists, dermatology nurses, and skin care industry researchers It will also earn a place in the libraries ofgynecologists, medical aestheticians, family practitioners, and plasticsurgeons. Table of ContentsList of Contributors, ix Foreword, xiii Preface, xiv Part I: Basic Concepts, 1 Section 1: Skin Physiology Pertinent to Cosmetic Dermatology, 3 1 Epidermal Barrier, 5Sreekumar Pillai, Megan Manco, Christian Oresajo, and Nada Baalbaki 2 Photoaging, 16Kalee Shah, Kira Minkis, Jillian Havey Swary, and Murad Alam 3 Pigmentation and Skin of Color, 26Jasmine C. Hollinger, Chesahna Kindred, and Rebat M. Halder 4 The Somatosensory System and Sensitive Skin, 37Francis McGlone, David Reilly, and Zoe Diana Draelos 5 Novel, Compelling, Noninvasive Techniques for Evaluating Cosmetic Products, 47Thomas J. Stephens and Lily I. Jiang 6 Contact Dermatitis and Topical Agents, 57Emily C. Milam, Alexandra Price, Sarika Ramachandran, and David E. Cohen 7 Skin Exposome, 72Gabrielle Sore and Stephen Lynch 8 Skin Microbiome: General Overview and Application Perspectives, 79Magali Moreau and Yaxian Zhen Section 2: Delivery of Cosmetic Skin Actives and Product Labeling, 89 9 Percutaneous Delivery of Cosmetic Actives to the Skin, 91Sreekumar Pillai, Surabhi Singh, Christian Oresajo, and Nada Baalbaki 10 Creams and Ointments, 101Irwin Palefsky 11 International Nomenclature Chemical Ingredient Dictionary and Handbook: Back-Label Ingredient Statement, 106Eric S. Abrutyn Part II: Hygiene Products, 115 Section 1: Cleansers, 117 12 Bar Cleansers, 119K.P. Ananthapadmanabhan and Stacy Hawkins 13 Personal Cleansers: Body Washes, 134Keith Ertel, Heather Focht, and Karl Wei 14 Facial Cleansers and Cleansing Cloths, 144Susan Griffiths-Brophy, Erik J. Hasenoehrl, and Karl Wei 15 Hand Cleansers and Sanitizers, 151Duane Charbonneau 16 Shampoos for Normal Scalp Hygiene and Dandruff, 165James R. Schwartz, Eric S. Johnson, and Thomas L. Dawson Section 2: Moisturizers, 175 17 Understanding the 4 Key Elements of Skin Moisturization, 177Eric S. Abrutyn 18 Facial Moisturizers, 182Yohini Appa 19 Hand and Foot Moisturizers, 189Teresa M. Weber, Frank Rippke, Elke Groenniger, and Andrea M. Schoelermann 20 Sunless Tanning Products, 200Peter Foltis, Angelike Galdi, and Christian Oresajo 21 Sunscreens, 204Angelike Galdi, Peter Foltis, Brian Bodnar, Dominique Moyal, and Christian Oresajo Section 3: Personal Care Products, 213 22 Antiperspirants and Deodorants, 215Eric S. Abrutyn 23 Blade Shaving, 223Kevin Cowley, Kristina Vanoosthuyze, Gillian McFeat, and Keith Ertel Part III: Adornment, 231 Section 1: Colored Facial Cosmetics, 233 24 Facial Foundation, 235Sylvie Guichard, Véronique Roulier, Brian Bodnar, and Audrey Ricard 25 Camouflage Techniques, 244Anne Bouloc 26 Lips and Lipsticks, 252Catherine Heusèle, Hervé Cantin, and Frédéric Bonté 27 Eye Cosmetics, 259Florante Ricarte, David Singh, Pamela Wong-Putnam, and Sarah A. Vickery Section 2: Nail Cosmetics, 269 28 Nail Physiology and Grooming, 271Anna Hare and Phoebe Rich 29 Colored Nail Cosmetics and Hardeners, 280Paul H. Bryson 30 Cosmetic Prostheses as Artificial Nail Enhancements, 289Douglas Schoon Section 3: Hair Cosmetics, 299 31 Hair Physiology and Grooming, 301Maria Hordinsky, Sherman Chu, Ana Paula Avancini Caramori, and Jeff C. Donovan 32 Hair Dyes, 309Rene C. Rust and Harald Schlatter 33 Permanent Hair Waving, 320Annette Schwan-Jonczyk, Gerhard Sendelbach, Andreas Flohr, and Rene C. Rust 34 Hair Straightening, 331Harold Bryant, Michael DeGeorge, Felicia Dixon, Angela Ellington, Andrew Greaves, and Crystal Porter 35 Hair Styling: Technology and Formulations, 340Thomas Krause and Rene C. Rust Part IV: Anti-aging, 351 Section 1: Cosmeceuticals , 353 36 Botanicals, 355Carl R. Thornfeldt 37 Antioxidants and Anti-inflammatories, 366Bryan B. Fuller 38 Peptides and Proteins, 388Karl Lintner 39 Cellular Growth Factors and Exosomes, 401Rahul C. Mehta, Gail K. Naughton, and Mitchel P. Goldman 40 Topical Cosmeceutical Retinoids, 408Olivier Sorg, Gürkan Kaya, and Jean H. Saurat 41 Topical Vitamins, 420John E. Oblong and Joseph H. Jansen 42 Clinical Uses of Hydroxyacids, 430Barbara A. Green, Eugene J. Van Scott, and Ruey J. Yu 43 The Contribution of Dietary Nutrients and Supplements to Skin Health, 442Helen Knaggs, Mark Bartlett, Steve Wood, Doug Burke, and Jin Namkoong Section 2: Injectable Anti-aging Techniques, 451 44 Botulinum Toxins, 453Margit L.W. Juhasz, Scott R. Freeman, and Joel L. Cohen 45 Hyaluronic Acid Fillers, 466Mark S. Nestor and Daniel Fischer 46 Calcium Hydroxylapatite for Soft Tissue Augmentation, 474Stephen Mandy 47 Autologous Skin Fillers, 479Amer H. Nassar, Andrew S. Dorizas, and Neil S. Sadick 48 Polylactic Acid Fillers, 485Jacob Beer, Soraya Azzawi, Kenneth R. Beer, and Aigen Alyx Rosen Section 3: Resurfacing and Rejuvenation Techniques, 495 49 Superficial Chemical Peels, 497M. Amanda Jacobs, Randall Roenigk, and Cassondra A. Ellison 50 Medium-Depth Chemical Peels, 505Gary D. Monheit and Katherine T. Hrynewycz 51 Ablative Laser Resurfacing: Confluent and Fractionated, 516Michael B. Lipp, Kunal Angra, and Mitchel P. Goldman 52 Non-ablative Lasers, 535Katarina R. Kesty and David J. Goldberg 53 Dermabrasion, 547Christopher B. Harmon and Daniel P. Skinner 54 Radiofrequency Microneedling in Cosmetic Dermatology, 555Shaun Wootten and Lawrence A. Rheins 55 The Growing Role for Platelet Rich Plasma in Cosmetic Dermatology, 561Lawrence A. Rheins, Shaun Wootten, and Lynn Begovac Section 4: Implementation of Cosmetic Dermatology into Therapeutics, 569 56 Antiaging Regimens, 571Karen E. Burke 57 Over-the-Counter Acne Treatments, 587Kirsten Swenson, Emmy M. Graber, and Diane Thiboutot 58 Rosacea Regimens, 598Joseph Bikowski and Zoe Diana Draelos 59 Eczema Regimens, 606Zoe Diana Draelos 60 Psoriasis Regimens, 612Arjun M. Bashyam, Varun K. Ranpariya, and Steven R. Feldman Index, 618
£162.85
John Wiley and Sons Ltd The Drug Recognition Guide
Book SynopsisThe Drug Recognition Guide introduces an innovative method for recognising and categorising medications, enabling readers to easily identify the type and use of a generic drug by visually deconstructing its name. Through its creative use of colour-coded drug prefixes and suffixes, this pocket-sized guide makes generic drug names distinctive, logical, and easy to pronounce and remember. More than 700 drugs from over 200 different drug categories are catalogued and colour-highlightedhelping you understand what underlies a generic drug name. Organised by class and use, the book's ten chapters cover a comprehensive range of drugs, including chemotherapy and immunosuppressants, drugs that affect the cardiovascular and respiratory systems, drugs used to manage pain, treat infectious diseases, and many others. Each entry briefly summarises a particular class of drugs, describes the intended use of drugs within the class, and breaks down the name stems of individual drugs to reveal useful information and illustrate connections between chemically and therapeutically related medicines. Presenting an original, easy-to-use approach to the complex subject of drug classification, this invaluable learning aid: Provides a thorough yet accessible way for students and practitioners to increase their understanding of medications and their applicationHelps students to clearly read and pronounce even the most difficult generic drug namesHighlights the letters in generic drug names to enable students to recognise drugs immediatelyExplains who assigns a generic drug name and what the name representsIncludes an introduction to generic and proprietary drug names and design motifs The Drug Recognition Guide is essential reading for nursing and medical students, pharmacy students and technicians, as well as nurse practitioners and trainee and junior doctors.Table of ContentsForeword ix Introduction xi 1 Drugs that affect the gastrointestinal system 1 2 Drugs that affect the cardiovascular system 7 3 Drugs that affect blood coagulation and lipids 21 4 Drugs that affect the respiratory system 31 5 Drugs that affect the central and peripheral nervous system 35 6 Drugs used in the management of pain 51 7 Antiemetics: drugs used in the management of nausea and vomiting 59 8 Diabetes drug therapy and other medicines that affect the endocrine system 65 9 Antimicrobials: drugs used to treat infectious diseases 77 10 Chemotherapy and immunomodulating agents 89 Index of Drugs Groups 99 Index of Drugs 105
£26.55
Wiley-Blackwell Nucleic Acids in Medicinal Chemistry and Chemical
Book SynopsisTable of ContentsChapter 1. Phosph(on)ate Prodrugs-prof.Junbiao Chang.docx chapter 2-Cyclic Dinucleotides A New Generation Drug for Immune Therapy-prof Xi.docx Chapter 3-Enzymatic and Endogenous Synthesis of NAD(P)-derived Calcium-mobilizing Messengers-Prof Lee.docx Chapter 4-Selenium Atom-modified Nucleic Acids for Structural, Functional and Diagnostic Studies-prof huang.docx chapter 5-Sequence-specific chromosomal DNA binders an unfulfilled promise-Prof Sugiyama.docx chapter 6- DNA synthesis and synthetic genome-prof Yuan.docx Chapter 7-Methods for mapping of nucleic acids epigenetic modifications and its clinic applications-prof zhou.docx Chapter 8-main text.docx Chapter 9-nucleic acid-based nanocarriers as drug delivry system-Prof. Jongbum Lee-no figure.docx Chapter 10.docx Chapter 11-Oligonucleotide therapeutics-Prof. Yang.docx Chapter 12-CRISPRCas9 a therapeutic solution by manipulating nucleic acids-prof.Deng.docx chapter 13-Aptamer properties, functions and applications-prof Tan.docx chapter 14-G-quadruplex as a platform for new perspectives in nucleic acid targeting for therapeutic applications-Prof.Sissi.doc
£171.00
Wiley-Blackwell Bladder Pathology
Book Synopsis
£208.76
John Wiley and Sons Ltd Leadership in Veterinary Medicine
Book SynopsisTable of ContentsAcknowledgements xii Foreword xiv Part I Foundations of Veterinary Leadership 1 1 Introduction 3 1.1 What Is Leadership, and Why Do We Need a Book on Veterinary Leadership? 3 1.2 My Leadership Experiences 5 1.3 My Approach 5 1.4 Who Is the Book for? 6 1.5 How to Use This Book 6 1.6 What Is ‘Good Enough’? 6 Questions 7 Further Reading 7 References 7 2 Veterinary Leadership in Context 8 2.1 Introduction 8 2.2 Complex Systems and Wicked Problems 9 2.3 What Is a Profession? 10 2.4 The History of the Veterinary Profession 11 2.5 What Are the Veterinary Professions, and What Are They for? 12 2.6 Uncertainties of Role and Identity 13 2.7 Professional Archetypes 14 2.8 Why Is Leadership Important in the Veterinary Professions? 14 2.9 Veterinary Teams 15 2.10 What Difference Does Leadership Make? 16 2.11 The Discipline of ‘Leadership’ in Veterinary Medicine 17 2.12 The Future of Leadership in Veterinary Medicine 18 2.13 Conclusion 19 Questions 19 Further Reading 20 References 20 3 Leadership Repertoires 23 3.1 Introduction 23 3.2 Cognitive Competencies 25 3.3 Emotional Competencies 29 3.4 Intuition 32 3.5 Conclusion 34 Questions 34 Further Reading 35 References 35 4 Self-Leadership 37 4.1 Introduction 37 4.2 Self-Awareness 38 4.3 How Do Others See Your Leadership? 42 4.4 How Do you Want Others to See Your Leadership? 45 4.5 Self-Motivation 46 4.6 Self-Regulation 47 4.7 Leadership Traps and Shadows 49 4.8 Self-Development 51 4.9 Self-Care 52 4.10 Conclusion 55 Questions 55 Further Reading 56 References 56 5 Veterinary Professionals and Leadership 59 5.1 Are Veterinary Professionals Different? 59 5.2 The Leadership–Followership Dynamic 67 5.3 What Do Veterinary Professionals Want from Leadership? 70 5.4 It’s Not Just the Veterinary Professionals 72 5.5 Conclusion 72 Questions 73 Further Reading 73 References 73 6 Analysing Organisations 76 6.1 Introduction 76 6.2 Why Do Organisations Differ? 77 6.3 How Organisations Differ 77 6.4 Analysing Organisations 87 6.5 How Do Organisations Develop? 93 6.6 Leadership and the Organisational Context 94 6.7 Conclusion 94 Questions 95 Further Reading 95 References 95 7 Understanding Strategy 97 7.1 Introduction 97 7.2 Strategy Now 98 7.3 Strategy Then? 103 7.4 Strategy How? 108 7.5 Conclusion 112 Questions 112 Further Reading 113 References 113 8 Communicating and Engaging 114 8.1 Introduction 114 8.2 How Do We Communicate? 115 8.3 What You Want to Say Is Not (Necessarily) What I Hear 117 8.4 Types of Communication 118 8.5 If You Want to Be Heard, First Listen 118 8.6 Asking Great Questions 119 8.7 Think About Your Intended Audience 120 8.8 What Message Is Received? 121 8.9 Putting It Together 122 8.10 Engagement and Authenticity 123 8.11 What If They Don’t Want to Listen? 124 8.12 Negotiation 125 8.13 Conflict and Conflict Management Styles 126 8.14 Mediation 127 8.15 Difficult Conversations 128 8.16 Conclusion 129 Questions 130 Further Reading 130 References 130 9 Creating Effective Teams 132 9.1 Introduction 132 9.2 Who Is the Team? 133 9.3 What Is the Shared Purpose? 136 9.4 Shared Leadership 139 9.5 Relational Team Leadership 140 9.6 Creating the Right Team Environment 145 9.7 Task Leadership 145 9.8 If, and When, to Intervene 147 9.9 Team Maintenance 147 9.10 When Teams End 148 9.11 Conclusion 149 Questions 149 Further Reading 149 References 149 10 Leadership and Change 153 10.1 What Is Change? 154 10.2 Systemic Perspectives on Change 155 10.3 Psychological Aspects of Change 158 10.4 Change Leadership 160 10.5 Adoption and Diffusion of Change 166 10.6 Conclusion 169 Questions 170 Further Reading 170 References 170 11 Remote and Virtual Leadership 174 11.1 Introduction 174 11.2 Definitions 175 11.3 Considerations for Remote Leadership 176 11.4 Remote Leadership Tasks 178 11.5 Considerations for Virtual Leadership 180 11.6 Virtual Leadership Tasks 185 11.7 Informal Virtual Leadership 188 11.8 Hybrid Models 189 11.9 Conclusion 189 Questions 190 Further Reading 190 References 190 12 Leadership and Development 193 12.1 Introduction 193 12.2 What Are You Developing? 194 12.3 Does Leadership Development Work? 195 12.4 Engagement and Motivation to Develop Leadership 195 12.5 Developing a Leadership Identity 197 12.6 Kolb Experiential Learning Cycle 198 12.7 Creating a Feedback Culture 200 12.8 Choices for Leadership Development 202 12.9 Succession Planning 207 12.10 Conclusion 209 Questions 209 Further Reading 209 References 209 13 Leadership in Practise 214 13.1 Introduction 214 13.2 Choose Your Behaviours 214 13.3 Be Brave and Authentic 215 13.4 Be Decisive and Assertive 215 13.5 Be Honest, Fair, and Transparent 216 13.6 Have Integrity and Trustworthiness 216 13.7 Own Your Failures 216 13.8 Be Grateful and Positive 217 13.9 Understand the Organisation 217 13.10 Get to Know the People 218 13.11 Think of the Group 218 13.12 Align and Create Direction 218 13.13 Trust 219 13.14 Empower 219 13.15 Nurture 220 13.16 Protect 221 13.17 Be Tough on Standards and Kind to People 221 13.18 Connect 221 13.19 Make Time 222 13.20 Follow 222 13.21 Accept Messiness and Dance with Complexity 222 13.22 Conclusion 222 Questions 223 Further Reading 223 References 223 Part II Veterinary Leadership Scenarios 225 Scenario 1 A Thief in the House? 228 Scenario 2 A Failed Strategy? 229 Scenario 3 ‘What Do You Think You Are Doing?’ 230 Scenario 4 At Last, a Proper Lunch Break! 231 Scenario 5 Not a Trivial Matter 232 Scenario 6 Convincing the Board 233 Scenario 7 A Tough First Time 234 Scenario 8 A New Broom? 235 Scenario 9 A Bit of a Beef 236 Scenario 10 Into the Lion’s Den 237 Scenario 11 Our Planet Is at Stake! 238 Scenario 12 Creating a New Future 239 Scenario 13 On the Horns of a Dilemma 240 Appendix A Behavioural Drivers Questionnaire 241 Index 243
£41.75
John Wiley and Sons Ltd Magnetic Nanoparticles in Human Health and
Book SynopsisMagnetic Nanoparticles in Human Health and Medicine Explores the application of magnetic nanoparticles in drug delivery, magnetic resonance imaging, and alternative cancer therapy Magnetic Nanoparticles in Human Health and Medicine addresses recent progress in improving diagnosis by magnetic resonance imaging (MRI) and using non-invasive and non-toxic magnetic nanoparticles for targeted drug delivery and magnetic hyperthermia. Focusing on cancer diagnosis and alternative therapy, the book covers both fundamental principles and advanced theoretical and experimental research on the magnetic properties, biocompatibilization, biofunctionalization, and application of magnetic nanoparticles in nanobiotechnology and nanomedicine. Chapters written by a panel of international specialists in the field of magnetic nanoparticles and their applications in biomedicine cover magnetic hyperthermia (MHT), MRI contrast agents, biomedical imaging, modeling and simulation, nanobiotechnology, toxicity issues, and more. Readers are provided with accurate information on the use of magnetic nanoparticles in diagnosis, drug delivery, and alternative cancer therapeuticsfeaturing discussion of current problems, proposed solutions, and future research directions. Topics include current applications ofmagneticiron oxide nanoparticles in nanomedicine and alternative cancer therapy: drug delivery, magnetic resonance imaging, superparamagnetic hyperthermia as alternative cancer therapy, magnetic hyperthermia in clinical trials, and simulating the physics of magnetic particle heating for cancer therapy. This comprehensive volume: Covers both general research on magnetic nanoparticles in medicine and specific applications in cancer therapeuticsDiscusses the use of magnetic nanoparticles in alternative cancer therapy by magnetic and superparamagnetic hyperthermiaExplores targeted medication delivery using magnetic nanoparticles as a future replacement of conventional techniquesReviews the use of MRI with magnetic nanoparticles to increase the diagnostic accuracy of medical imaging Magnetic Nanoparticles in Human Health and Medicine is a valuable resource for researchers in the fields of nanomagnetism, magnetic nanoparticles, nanobiomaterials, nanobioengineering, biopharmaceuticals nanobiotechnologies, nanomedicine, and biopharmaceuticals, particularly those focused on alternative cancer diagnosis and therapeutics.Table of ContentsList of Contributors 1. An introduction to magnetic nanoparticles: from bulk to nanoscale magnetism and their applicative potential in human health and medicine Costica Caizer1*, Shital Bonde2, and Mahendra Rai2 1West University of Timisoara, Department of Physics, Bd. V. Parvan no. 4, 300223 - Timisoara, Romania 2UGC-Basic Science Research Faculty, Department of Biotechnology, SGB Amravati University, Amravati - 444 602, Maharashtra, India Part I. Current Biomedical Applications of Magnetic Nanoparticles 2. Magnetic nanoparticles in nanomedicine Gabriela Fabiola Stiufiuc1, Cristian Iacovita2, Valentin Toma3, Rares Ionuț Stiufiuc2,3, Romulus Tetean1* and Constantin Mihai Lucaciu3 1 Faculty of Physics, "Babes-Bolyai" University, Cluj-Napoca, Romania 2MedFuture Research Center for Advanced Medicine, "Iuliu Hatieganu" University of Medicine and Pharmacy, Cluj-Napoca, Romania 3Faculty of Pharmacy, "Iuliu Hatieganu" University of Medicine and Pharmacy, Cluj-Napoca, Romania 3. Clustering of magnetic nanoparticles for nanomedicine Giacomo Mandriota1, Riccardo Di Corato2* 1Istituto Italiano di Tecnologia, via Morego 30, 16163 Genoa, Italy 2CNR-IMM, Institute for Microelectronics and Microsystems, Via Monteroni - Campus Ecotekne, 73100 Lecce, Italy 4. Multifunctional bioactive magnetic scaffolds with tailored features for bone tissue engineering Teresa Russo1*, Roberto De Santis1, Valentina Peluso2, Antonio Gloria1 1 Institute of Polymers, Composites and Biomaterials (IPCB) – National Research Council of Italy 2 Department of Neurosciences, Reproductive and Odontostomatological Sciences, University of Naples “Federico II”, Naples, Italy 5. Magnetic nanoparticles in the development of polymer scaffolds for medical applications Larissa Stieven Montagna, Ana Paula da Silva, Amanda de Sousa Martinez de Freitas, Ana Paula Lemes* Polymers and Biopolymers Technology Laboratory, (TecPBio), Department of Science and Technology, Federal University of Sao Paulo, São José dos Campos, SP, Brazil 6. Magnetic polymer colloids for ultrasensitive molecular imaging Sundas Riaz1, Sumera Khizar1, Nasir M. Ahmad1* Gul Shahnaz2 Noureddine Lebaz3 Abdelhamid Elaissari3* 1Polymer Research Lab, School of Chemical and Materials Engineering (SCME), National University of Sciences and Technology (NUST), H-12 Sector, Islamabad-44000, Pakistan 2Department of Pharmacy, Faculty of Biological Sciences, Quaid-i-Azam University, Islamabad-45320, Pakistan 3Univ Lyon, University Claude Bernard Lyon-1, CNRS, LAGEPP UMR-5007, 43 boulevard du 11 novembre 1918, F-69100, Villeurbanne, France 7. Iron oxide nanoparticles in anticancer drug delivery and imaging diagnostics Miroslava Nedyalkova1*, Boyan Todorov1, Haruna L. Barazorda-Ccahuanac2, Sergio Madurga3 1 Faculty of Chemistry and Pharmacy, Sofia University „St. Kliment Ohridski”, Sofia, Bulgaria 2 Centro de Investigación en Ingeniería Molecular-CIIM, Universidad Católica de Santa María, Arequipa, Perú 3 Faculty of Chemistry, Barcelona University, Barcelona, Spain 8. Functional addressable magnetic domains and their potential applications in theranostics Sihomara Patricia García-Zepeda1, Jaime Santoyo-Salazar2* 1Toxicology Department, Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional, CINVESTAV-IPN, 07360 Mexico City, Mexico 2*Physics Department, Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional, CINVESTAV-IPN, 07360 Mexico City, Mexico 9. Nuclear/MR magnetic nanoparticle-based probes for multimodal biomedical imaging Eirini Fragogeorgi1,2*, Sophia Sarpaki2, Maritina Rouchota2, Panagiotis Papadimitroulas2 and Maria Georgiou2 1Institute of Nuclear & Radiological Sciences, Technology, Energy & Safety (INRASTES), NCSR ‘‘Demokritos”, Ag. Paraskevi-Athens, Greece 2Bioemission Technology Solutions (BIOEMTECH), Lefkippos Attica Technology Park, NCSR “Demokritos”, Ag. Paraskevi-Athens, Greece Part II. Magnetic Nanoparticles in Alternative Cancer Therapy 10. Magnetic nanoparticles hyperthermia: the past, the present and the future Dawn Blazer, Yohannes Getahun, Ahmed A. El-Gendy*, University of Texas El Paso, Department of Physics, El Paso, TX 79968, USA 11. Drug delivery and magnetic hyperthermia based on surface engineering of magnetic nanoparticles Guilherme N. Lucena1,2, Caio C. dos Santos1, Gabriel C. Pinto1 Bruno E. Amantéa1, Rodolfo D. Piazza1, Miguel Jafelicci Jr1, Rodrigo Fernando C. Marques1,2,3* Laboratory of Magnetic Materials and Colloids, Department of Physical Chemistry, Institute of Chemistry, São Paulo State University (UNESP), BRAZIL 12. Improving magneto-thermal energy conversion efficiency of magnetic fluids through external DC magnetic field induced orientational ordering B. B. Lahiri, Surojit Ranoo, Fouzia Khan, John Philip Smart Materials Section, Corrosion Science and Techonlogy Division, Materials Characterization Group, Metallurgy amd Materials Group, Indira Gandhi Centre for Atomic Research, Kalpakkam, Tamil Nadu, PIN 603102, India 13. Classical Magnetoliposomes vs Current Magnetociclodextrins with Ferrimagnetic Nanoparticle for High Efficiency and Low Toxicity in Alternative Therapy of Cancer by Magnetic/ Superparamagnetic Hyperthermia Costica Caizer1*, Cristina Dehelean2, Codruta Soica2 1*West University of Timisoara, Faculty of Physics, Bv. V. Parvan no. 4, 300223 - Timisoara, Romania; e-mail: costica.caizer@e-uvt.ro 2“Victor Babes” University of Medicine and Pharmacy, Faculty of Pharmacy, P-zza. E. Murgu no. 2, 300041 – Timisoara, Romania 2“Victor Babes” University of Medicine and Pharmacy, Faculty of Pharmacy, P-zza. E. Murgu no. 2, 300041 – Timisoara, Romania 14. Efficiency of energy dissipation in nanomagnets: a theoretical study of AC susceptibility F. Vernay, J.-L. Déjardin, H. Kachkachi* Université de Perpignan via Domitia, Lab. PROMES CNRS UPR8521, Rambla de la Thermodynamique, Tecnosud, 66100 Perpignan, France 15. Magnetic Nanoparticle Relaxation in Biomedical Application: Focus on Simulating Nanoparticle Heating Ulrich M. Engelmann1,2*, Carolyn Shasha3, and Ioana Slabu2 1Department of MedicalEngineering and Applied Mathematics, FH Aachen University of Applied Sciences, Aachen, Germany 2Applied Medical Engineering, Helmholtz Institute, Medical Faculty, RWTH Aachen University,Aachen, Germany 3Department of Physics, University of Washington, Seattle, WA 98195, USA 16. Magnetic Nanoparticles in Alternative Tumors Therapy: Biocompatibility, Toxicity and Safety Compared with Classical Methods Costica Caizer1 and Mahendra Rai2 1West University of Timisoara, Department of Physics, Bd. V. Parvan no. 4, 300223 - Timisoara, Romania 2UGC-Basic Science Research Faculty, Department of Biotechnology, SGB Amravati University, Amravati - 444 602, Maharashtra, India 17. The size, shape and composition design of iron oxide nanoparticles to combine MRI, magnetic hyperthermia and photothermia Barbara Freis1, Geoffrey Cotin1, Francis Perton1 Damien Mertz1, Sylvie Begin-Colin1* Sophie Laurent2,3 Sebastien Boutry2,3 1Université de Strasbourg, CNRS, Institut de Physique et Chimie des Matériaux de Strasbourg, UMR 7504, F-67034 , Strasbourg, France 2Université de Mons, General, Organic and Biomedical Chemistry Unit, NMR and Molecular Imag-ing Laboratory, 7000 , Mons, Belgium 3. Center for Microscopy and Molecular imaging (CMMI), Gosselies, Belgium 18. Magnetic/Superparamagnetic hyperthermia in clinical trials for non-invasive alternative cancer therapy Costica Caizer West University of Timisoara, Department of Physics, Bv. V. Parvan no. 4, 300223 - Timisoara, Romania Index
£139.45
John Wiley and Sons Ltd MRI Registry Review
Book SynopsisTable of ContentsAbout the Author vii Acknowledgements Viii 1 Patient Interactions and Management 1 Below are artist renditions of the anatomical position: 31 Section 1 Patient Interactions and Management Answers 31 Enlarged Pictures 43 2 Parameters, Image Formation, Data Acquisition 45 Section 2: Parameters, Image Formation, Data Acquisition: Answers 93 Section 2 Question 41–54 96 Section 2: Enlarged Illustrations 107 Section 2 Questions 41–54 108 Chapter 2: Parameters, Image Formation, Data Acquisition 109 3 Pulse Sequences and MRI Math 113 Use the factors listed below for Questions 200–203 154 Section 3 MR Pulse Sequences and MR Math Answers 177 4 Procedures 192 Image Artifacts 275 Remember, Choose the Answer Most Correct 275 Artifacts 293 Miscellaneous Questions: 297 Helpful Anatomy: The Basil Ganglia 307 Helpful Anatomy: T2 Axials of Basil Ganglia 308 Helpful Anatomy: T1 Sagittal of Brain Stem 308 Other Helpful Anatomy: The Brachial Plexus 309 The Boney Pelvis 310 The Cranial Nerves: O O O T T A F A G V A H 311 Cranial Nerve: Study 312 T1 and T2 Contrast Differences in the Brain 312 Answers 313 MRI Math 339 Glossary 350 Index 375
£40.80
Wiley-Blackwell Formulating Pharma Nutra and Cosmeceutical Pro ducts from Herbal Substances Dosage Forms and Del ivery Systems
£171.00
John Wiley & Sons Inc TraumaInformed Parenting Program
Book SynopsisAn essential handbook for clinicians planning to involve the parents of trauma-impacted children in the treatment process In Trauma-Informed Parenting Program: TIPs for Clinicians to Train Parents of Children Impacted by Trauma & Adversity, distinguished behavioral healthcare practitioner, Dr. Carryl P. Navalta, delivers a practical and hands-on guide for clinicians to assist clients, and their families with emotion regulation in the face of trauma. In the book, readers will discover how to assess, conceptualize, and treat children suffering from the effects of exposure to various forms of trauma and adversity and to provide their clients' parents with the tools neccessary to facilitate further healing in the home and beyond. TIPs also Provides: A thorough introduction to trauma that describes the historical roots and prevalence of trauma as well as the impact of adverse childhood experiences on child development and emotion regulationA comrehensive exploration of case conceptualization and the creation of clinical formulations that identify, define, and integrate the primary problems facing the clientA fulsome discussion of treatment planning, including goal development, objective construction, intervention creation, and diagnosis determinationPsychologists can earn 6 continuing credits by reading the book and taking a post-test. This professional learning activity is offered by the National Prevention Science Coalition to Improve Lives An indespensible resource for clinicians dealing with trauma-impacted children, Trauma-Informed Parenting Program will earn a plce in the libraries of mental health counselors, social works, psychologists, psychiatrists, and all the practitioners who seek to make the parents of their clients an integral and usefual part of the treatment process.Table of ContentsForeword ix Acknowledgements xi About the Companion Website xiii 1 Introduction and Foundations 1 2 Clinical Assessment 22 3 Case Conceptualization 39 4 Treatment Planning 57 5 Guidelines for Clinicians 76 6 Final Thoughts . . . . and Skills 123 Appendix A Case Conceptualization Development Form 129 Appendix B Treatment Planning Form 131 Appendix C Emotion Identification Worksheet 133 Appendix D Problem-Solving Steps 135 References 137 Index 163
£29.44
John Wiley & Sons Supervised and Unsupervised Data Engineering for
Book Synopsis
£140.40
John Wiley and Sons Ltd AI in Clinical Medicine
Book SynopsisTable of ContentsList of Contributors xii Foreword xxiv Preface xxvi Michael Byrne Acknowledgements xxx Relevant AI Terms xxxii About the Companion Website xxxvi SECTION I Overview of Medical AI: The What, the Why, and the How 1 1 An Introduction to AI for Non-Experts 3Sharib Ali and Michael Byrne 2 General Framework for Using AI in Clinical Practice 13Judy L Barkal, Jack W Stockert, Jesse M Ehrenfeld, Charles E Aunger, and Lawrence K Cohen 3 AI and Medical Education 27Alexandra T Greenhill SECTION II AI Foundations 39 4 History of AI in Clinical Medicine 41Isaak Kavasidis, Federica Proietto Salanitri, Simone Palazzo, and Concetto Spampinato 5 History, Core Concepts, and Role of AI in Clinical Medicine 49Christoph Palm 6 Building Blocks of AI 56Ulas Bagci, Ismail Irmakci, Ugur Demir, and Elif Keles 7 Expert Systems for Interpretable Decisions in the Clinical Domain 66Syed Muhammad Anwar 8 The Role of Natural Language Processing in Intelligence-Based Medicine 73Maryam Panahiazar, Nolan Chen, Ramin E Beygui, and Dexter Hadley SECTION III AI Applied to Clinical Medicine 81 Frontline Care Specialties 9 AI in Primary Care, Preventative Medicine, and Triage 83Yasmin Abedin, Omer F Ahmad, and Junaid Bajwa 10 Do It Yourself: Wearable Sensors and AI for Self-Assessment of Mental Health 94Harish RaviPrakash and Syed Muhammad Anwar 11 AI in Dentistry 104Lyudmila Tuzova, Dmitry Tuzoff, and L Eric Pulver 12 AI in Emergency Medicine 117Jonathon Stewart, Adrian Goudie, Juan Lu, and Girish Dwivedi Medical Specialties 13 AI in Respirology and Bronchoscopy 129Kevin Deasy, Henri Colt, and Marcus Kennedy 14 AI in Cardiology and Cardiac Surgery 144Lin Gu 15 AI in the Intensive Care Unit 154Dipayan Chaudhuri and Sandeep S Kohli 16 AI in Dermatology 165Albert T Young, Jennifer Y Chen, Abhishek Bhattarcharya, and Maria L Wei 17 Artificial Intelligence in Gastroenterology 176Trent Walradt and Tyler M Berzin 18 AI in Haematology 184Paulina B Szklanna, Luisa Weiss, Brian Mac Namee, Rehman Faryal, Barry Kevane, Fionnuala Ní Áinle, and Patricia B Maguire 19 AI and Infectious Diseases 192Alanna Ebigbo and Helmut Messmann 20 AI in Precision Medicine: The Way Forward 200Prasun J Mishra 21 AI in Paediatrics 210Darren Gates and Iain Hennessey 22 AI Applications in Rheumatology 219Sarah Quidwai, Colm Kirby, and Grainne Murphy Surgical Specialties 23 Perspectives on AI in Anaesthesiology 228Vesela Kovacheva 24 AI in Ear, Nose, and Throat 233Jesús Rogel-Salazar and Krishan Ramdoo 25 AI in Obstetrics and Gynaecology 239Sam Mathewlynn and Lucy Mackillop 26 AI in Ophthalmology 253Nima John Ghadiri 27 AI in Orthopaedic Surgery 266David Burns, Aazad Abbas, Jay Toor, and Michael Hardisty 28 AI in Surgery 282Jesutofunmi A Omiye, Akshay Swaminathan, and Elsie G Ross 29 AI in Urological Oncology: Prostate Cancer Diagnosis with Magnetic Resonance Imaging 298Sherif Mehralivand and Baris Turkbey Diagnostic Specialties 30 AI in Pathology 307Stephanie Harmon and Kevin Ma 31 Introduction to AI in Radiology 318Shu Min Yu and Amarpreet Mahil 32 Clinical Applications of AI in Diagnostic Imaging 321Mohammed F Mohammed, Savvas Nicolaou, and Adnan Sheikh 33 AI for Workflow Enhancement in Radiology 337Sabeena Jalal, Jason Yao, Savvas Nicolaou, and Adnan Sheikh 34 AI for Medical Image Processing: Improving Quality, Accessibility, and Safety 350Leonid L Chepelev, Savvas Nicolaou, and Adnan Sheikh 35 Future Developments and Assimilation of AI in Radiology 365Aakanksha Agarwal and Timothy É Murray SECTION IV Policy Issues, Practical Implementation, and Future Perspectives in Medical AI 377 AI Regulation, Privacy, Law 36 Medical Device AI Regulatory Expectations 379Vesna Janic, Helen Simons, and Taimoor Khan 37 Privacy Laws in the USA, Europe, and South Africa 395Sara Gerke 38 AI-Enabled Consumer-Facing Health Technology 407Alexandra T Greenhill Ethics, Equity, Bias 39 Biases in Machine Learning in Healthcare 426Dora Huang, Leo Anthony Celi, and Zachary O'Brien 40 'Designing' Ethics into AI: Ensuring Equality, Equity, and Accessibility 437Lisa Murphy Design and Implementation 41 Making AI Work: Designing and Evaluating AI Systems in Healthcare 448Niels van Berkel 42 Demonstrating Clinical Impact for AI Interventions: Importance of Robust Evaluation and Standardized Reporting 459Gagandeep Sachdeva, Diana Han, Pearse A Keane, Alastair K Denniston, and Xiaoxuan Liu 43 The Importance and Benefits of Implementing Modern Data Infrastructure for Video-Based Medicine 469Matt Schwartz and Ian Strug The Way Forward 44 AI and the Evolution of the Patient--Physician Relationship 478Judy L Barkal, Jack W Stockert, Jesse M Ehrenfeld, and Lawrence K Cohen 45 Virtual Care and AI: The Whole Is Greater Than the Sum of Its Parts 488Junaid Kalia 46 Summing It All Up: Evaluation, Integration, and Future Directions for AI in Clinical Medicine 498Mark A Shapiro and Marty Tenenbaum 47 A Glimpse into the Future: AI, Digital Humans, and the Metaverse -- Opportunities and Challenges for Life Sciences in Immersive Ecologies 521Siddharthan Surveswaran and Lakshmi Deshpande Index 528
£90.00
John Wiley and Sons Ltd Psychodynamic Formulation
Book SynopsisPsychodynamic Formulation A leading text for psychodynamic clinicians and practitioners Psychodynamic Formulation: An Expanded Approach delivers an exceptional exploration of psychodynamic explanations and hypotheses that seek to explain how a person's conscious and unconscious thoughts and feelings may have developed and may be causing or contributing to the challenges they face. This latest edition of the leading reference includes a refreshed and reinvigorated emphasis on the impacts of culture and society, as well as the importance of diversity and inclusion, on psychodynamic formulation. It puts new focus on lived experience, including trauma, and on how clinical bias can contribute to the perpetuation of trauma. In addition to newly included activities and exercises, readers will find: A practical, step-by-step guide to collaboratively creating psychodynamic formulationsComprehensive discussions about how what we're born with and environmental influences contribute to developmentSuggestions for using psychodynamic formulations in many clinical settings, including acute care and psychopharmacologic treatmentAn educator's guide to teaching psychodynamic formulation Perfect for mental health practitioners with a professional or personal interest in psychodynamics/psychoanalysis, Psychodynamic Formulation: An Expanded Approach will earn a place in the libraries of trainees in all mental health fields.Table of ContentsPreface x Acknowledgments xiv PART ONE Introduction to the Psychodynamic Formulation 1 1 What Is a Psychodynamic Formulation? 3 2 How Do We Create a Psychodynamic Formulation? 10 3 How Do We Use Psychodynamic Formulations? 14 4 Psychodynamic Formulation and Bias 18 5 Who We Are Affects Our Formulations 23 PART TWO DESCRIBE 29 6 Self 35 7 Relationships 44 8 Adapting 53 9 Cognition 62 10 Values 76 11 Work and Play 84 Putting It Together--DESCRIBE Problems And Patterns 93 PART THREE REVIEW 97 12 What We’re Born With 105 13 The Earliest Years 121 14 Middle Childhood 135 15 Later Childhood 143 16 Adolescence 149 17 Adulthood 155 Putting It Together--REVIEW a Life Story 161 PART FOUR LINK 165 18 Trauma 169 19 Early Cognitive and Emotional Difficulties 181 20 The Effects of Culture and Society 193 21 Conflict and Defense 205 22 Relationships with Others 214 23 The Development of the Self 225 24 Attachment 235 Putting It Together--LINK to Collaboratively Create Psychodynamic Formulations 247 PART FIVE Psychodynamic Formulations in Clinical Practice 261 25 Psychodynamic Formulations in Acute Care Settings 263 26 Psychodynamic Formulations in Pharmacologic Treatment 273 27 Psychodynamic Formulations in Long-Term Psychodynamic Psychotherapy 282 28 Collaborative Formulations in Clinical Practice 291 End Note 298 Appendix A - An Educator's Guide to Using Psychodynamic Formulation: An Expanded Approach 299 Appendix B - DESCRIBE, REVIEW, LINK--An Outline 305 Recommended Reading 307 Index 316
£42.74
John Wiley & Sons Inc Blood Cells
Book SynopsisA comprehensive discussion of haematological morphology In the newly revised Sixth Edition of Blood Cells: A Practical Guide, expert haematologist Barbara J. Bain delivers a robust guide for use in the diagnostic hematology laboratory, covering methods of collection of blood specimens, blood film preparation and staining, the principles of manual and automated blood counts, and the assessment of the morphological features of blood cells. The book functions well as both a straightforward and practical bench manual and as a reference source for practicing hematologists. It has been completely updated to incorporate newly published information and 400 high-quality photographs to aid in blood cell identification. The text is comprehensive and fully supported by references. A companion website contains multiple-choice questions to aid the reader in retaining the information contained within. While the book provides additional guidance on further tests that should be performed for specific provisional diagnoses, the main focus of the text remains on microscopy and the automated full blood count. It also contains: A thorough introduction to blood sampling and blood film preparation and examination, as well as performance of blood countsComprehensive exploration of the morphology of blood cells, detecting erroneous blood counts, and normal rangesPractical discussions of quantitative changes in blood cells and important supplementary testsIn-depth examinations of disorders of red blood cells, white blood cells and plateletsReview of the morphological features of blood parasites Perfect for practicing haematologists and haematology trainees, Blood Cells: A Practical Guide will also earn a place in the libraries of biomedical scientists working in laboratory settings. Many laboratories worldwide regard it as an essential bench book.Table of ContentsPreface vi Acknowledgements vii List of Abbreviations viii About the Companion Website x 1 Blood sampling and blood film preparation and examination 1 2 Performing a blood count 17 3 Morphology of blood cells 64 4 Detecting erroneous blood counts 198 5 Normal ranges 222 6 Quantitative changes in blood cells 244 7 Important supplementary tests 301 8 Disorders of red cells and platelets 316 9 Disorders of white cells 461 Index 539
£98.06
John Wiley and Sons Ltd Handbook of Skin Disease Management
Book SynopsisTable of ContentsExpert Contributors Preface How to use this book Acanthosis nigricans – Tony Hulse Acne – Alison Layton Acne keloidalis – Dmitri Wall Acrodermatitis enteropathica Actinic keratosis – Catherine Harwood Alopecia areata – Matthew Harris Apthous ulcers – Jane Setterfield Atopic dermatitis – Carsten Flohr Basal Cell Carcinoma BCC – Venura Samarasinghe Behcet’s – Ruth Murphy Bowen’s – Samantha Keegan Bullous pemphigoid – Wedad Abdelrahman Calciphylaxis – Nelomi Anandagoda CCCA – Christos Tziotzios Chilblains – Charlotte Fleming Chondrodermatitis nodularis helicis chronicus – Venura S Chronic actinic dermatitis – Sally Ibbotson Contact dermatitis – Lucy Ostlere Darier disease – Jemima Mellerio Dermatitis Herpetiformis - Wedad Abdelrahman Dermatomyositis – Zainab Jiyad, Victoria Akhras and Arvind Kaul Dissecting cellulitis of the scalp – Christos Tziotzios Drug reactions – Haur Yueh Lee Erosive pustular dermatosis – Catherine Harwood Erythema multiforme – Haur Yueh Lee Erythema nodosum – Jamie Wee Female pattern hair loss – Dmitri Wall Folliculitis – Rachael Morris-Jones Folliculitis decalvans – Matthew Harris FFA – Christos Tziotzios Flushing – Tony Hulse Granuloma annulare – Leila Ferguson Grover’s disease – Tanya Bleiker GVHD – Yishi Tan Hailey-Hailey – Vanessa Pinder Hidradenitis suppurativa – Ruth Lamb Hiruitism – Tony Hulse Hyperhidrosis – Alya Abdul-Wahab Ichthyosis – Celia Moss Infantile haemangioma – Carsten Flohr Keloid – Rakesh Patalay Keratosis pilaris – Celia Moss Leg ulcers – many, see emails Lentigo maligna – Rakesh Patalaya Lichen planopilaris – Matthew Harris Lichen planus – Laurence Le Cleach and David De Berker Lichen sclerosus – Fiona Lewis Linear IgA disease – Wedad Abdelrahman Lipodermatosclerosis – many, see emails Lupus Erythematosus – Victoria Akhras, Zainab Jiyad and Arvind Kaul Lymphoedema – Many, see emails Male pattern hair loss – Christos Tziotzios Mastocytosis – Clive Grattan Melanoma – Victoria Akhras and Zainab Jiyad Melasma – Rakesh Patalay Mycosis Fungoides – Mary Wain Molloscum contagiosum – Leila Ferguson Morphea – Cate Orteu Palmoplantar keratoderma – Edel O’Toole Papular urticaria – Charlotte Fleming Polyarteritis Nodosa – Zainab Jiyad and Victoria Akhras Pemphigus vulgaris/foliaceous - Wedad Abdelrahman Periorificial dermatitis – Carsten Flohr Pigmented purpuric dermatosis – Alya Abdul-Wahab Pityriasis lichenoides – Sue Lewis-Jones Pityriasis versicolor – Rachael Morris-Jones Polymorphic Light Eruption – Sally Ibbotson Porokeratosis – Catherine Harwood Pruritus – Eugene Ong and Nelomi Anandagoda PRP – Jemima Mellerio Pseudofolliculitis barbae – Rachael Morris-Jones Psoriasis – Chris Griffiths Psychodermatology – Tony Bewley Pyoderma gangrenosum – Tony Ormerod Rosacea – Esther Van Zuuren Sarcoidosis – Eugene Ong Seborrheic dermatitis – Carsten Flohr Scabies – Rod Hay Squamous Cell Carcinoma – Samantha Keegan Sweet’s syndrome – Jamie Wee Telogen effluvium – Dmitri Wall Tinea – Rachael Morris-Jones Urticaria – Clive Grattan Urticarial vasculitis – Clive Grattan Vasculitis – Zainab Jiyad and Victoria Akhras Vitiligo – Jonathan Batchelor Vulvodynia – Julia Soo Warts – Jane Sterling Zinc deficiency – Jemima Mellerio Appendix: Content and overall review - Siobhan Carey Systemics and biologics - Ruth Lamb Essential lists - Imran Khan Alopecia biopsy protocols - Catherine Stefanato Hair loss in skin of colour - Emma Amaofo Index
£42.74
John Wiley and Sons Ltd Mollers Essentials of Pediatric Cardiology
Book SynopsisTable of ContentsPreface vii 1. Tools to diagnose cardiac conditions in children 1 2. Environmental and genetic conditions associated with heart disease in children 70 3. Classification and physiology of congenital heart disease in children 83 4. Anomalies with a left-to-right shunt in children 93 5. Conditions obstructing blood flow in children 146 6. Congenital heart disease with a right-to-left shunt in children 182 7. Unusual forms of congenital heart disease in children 230 8. Unique cardiac conditions in newborn infants 242 9. The cardiac conditions acquired during childhood 256 10. Abnormalities of heart rate and conduction in children 288 11. Congestive heart failure in infants and children 311 12. A healthy lifestyle and preventing heart disease in children 325 Additional reading 370 Index 371
£57.90
John Wiley and Sons Ltd Researching Medical Education
Book SynopsisTable of ContentsList of Contributors Foreword by Brian Hodges Foreword from ASME Foreword from AMEE Preface Part I Developing your practice as a health professions education researcher 1. Exploring versus measuring: considering the fundamental differences between qualitative and quantitative research Jennifer Cleland 2. Theory in healthcare education research: the importance of worldview Wendy McMillan 3. Constructivism: Learning Theories and Approaches to Research Anna MacLeod, Sarah Burm, and Karen Mann 4. Widening access to medicine: using mid-range theory to extend knowledge and understanding Sandra Nicholson, Kirsty Alexander, Maeve Coyle, and Jennifer Cleland 5. Developing the research question: setting the course for your research travels Jaunita Bezuidenhout, Champion Nyoni, Rhoda Meyer, and Susan van Schalkwyk 6. Researching technology use in health professions education: questions, theories, approaches Rachel Ellaway 7. Power analyses: planning, conducting and evaluating education research R. Brent Stansfield and Larry Gruppen 8. Navigating health professions education research: exploring your researcher identity, topic and community Janneke M. Frambach, Muhammad Zafar Iqbal, Pim Teunissen, and Susan van Schalkwyk 9. How to tell compelling scientific stories: tips for artful use of the research manuscript and presentation genres Lorelei Lingard and Erik Driessen Part II Methodologies and methods for health professions education research 10. What is known already: Reviewing evidence in health professions education Morris Gordon 11. Qualitative research methodologies: embracing methodological borrowing, shifting and importing Lara Varpio, Maria Athina (Tina) Martimianakis, and Maria Mylopoulos 12. Attuning to the social world: Ethnography in health professions education research Simon Kitto, Janet Alexanian, and Joanne Goldman 13. Visual methods in health professions research: purpose, challenges and opportunities Sayra Cristancho, Kori LaDonna, and Emily Field 14. Critical discourse analysis: questioning what we believe to be ‘true’ Morag Paton, Thirusha Naidu, Rene Wong, Cynthia Whitehead, and Ayelet Kuper 15. Functional and Corpus Linguistics in health professions education research: The study of language in use Abigail Konopasky and Brett A. Diaz 16. Challenging Epistemological Hegemonies: Researching Inequity and Discrimination in Health Professions Education Saleem Razack, Andrea Jane McKivett, and Marco Antonio de Carvalho Filho 17. Educational Neuroscience: current status and future opportunities Anke Sambeth, Steven Durning, Minna Huotilainen, and Anique de Bruin Part III Theory informing health professions education research 18. Sticking with messy realities: complexity Alan Bleakley and Jennifer Cleland 19. Activity theory Jenny Johnston and Helen Reid 20. Disentangling humans, technologies and things: Sociomaterial research in health professions education Rola Ajjawi, Margaret Bearman, and Anna MacLeod 21. Social cognitive theory: thinking and learning in social settings Dario Torre and Steven J. Durning 22. Learning and participatory practices at work: Understanding and appraising learning through workplace experiences Stephen Billett, Linda Sweet, and Christy Noble 23. Health behaviour theories: a conceptual lens to explore behaviour change Francois Cilliers, Christina St-Onge, and Cees van der Vleuten 24. Self-regulated learning in HPE: theoretical perspectives and research methods Anthony R. Artino Jr., Adam Gavarkovs, Ryan Brydges, and Larry D. Gruppen 25. Emotions and learning: cognitive theoretical and methodological approaches to studying the influence of emotions on learning Meghan McConnell and Kevin Eva 26. Research on instructional design in the health professions: from taxonomies of learning to whole-task models Jimmy Frèrejean, Diana H.J.M Dolmans, and Jeroen K. G. van Merrienboer 27. Cognitive load theory: researching and planning teaching to maximise learning Adam Szulewski, Tamara van Gog, Fred Paas, and John Sweller 28. Deliberate practice and mastery learning: origins of expert medical performance William C.l McGaghie and Theresa Kristopaitis 29. Closing comments: Building and sustaining capacity David Taylor and Trevor Gibbs 30. Conclusion Jennifer Cleland and Steven J. Durnin Index
£44.64
Wiley-Blackwell Functional Reconstruction of the Urinary Tract
Book Synopsis
£128.25
John Wiley & Sons Inc Concepts of TissueBiomaterial Interactions Funda
Book Synopsis
£83.66
John Wiley & Sons Inc Essential Practical NMR for Organic Chemistry
Book SynopsisEssential Practical NMR for Organic Chemistry A hands-on resource advocating an ordered approach to gathering and interpreting NMR data The second edition of Essential Practical NMR for Organic Chemistry delivers a pragmatic and accessible text demonstrating an ordered approach to gathering and interpreting NMR data. In this informal guide, you'll learn to make sense of the high density of NMR information through the authors' problem-solving strategies and interpretations. The book also discusses critical aspects of NMR theory, as well as data acquisition and processing strategy. It explains the use of NMR spectroscopy for dealing with problems of small organic molecule structural elucidation and includes a brand-new chapter on Nitrogen-15 NMR. Readers will also find: Strategies for preparing a sample, spectrum acquisition, processing, and interpreting your spectrumFulsome discussions of Carbon-13 NMR spectroscopyPractical treatments of quantification, safety procedures, and relevant software An ideal handbook for anyone involved in using NMR to solve structural problems, this latest edition of Essential Practical NMR for Organic Chemistry will be particularly useful for chemists running and looking at their own NMR spectra, as well as those who work in small molecule NMR. It will also earn a place in the libraries of undergraduate and post-graduate organic chemistry students.Table of ContentsPreface xiii 1 Getting Started 1 1.1 The Technique 1 1.2 Instrumentation 2 1.2.1 CW Systems 2 1.2.2 FT Systems 3 1.2.3 Probes 5 1.2.4 Shims 6 1.3 Origin of the Chemical Shift 7 1.4 Origin of ‘Splitting’ 8 1.5 Integration 11 2 Preparing the Sample 13 2.1 How Much Sample Do I Need? 14 2.2 Solvent Selection 15 2.2.1 Deutero Chloroform (CDCl3) 16 2.2.2 Deutero Dimethyl Sulfoxide (DMSO) 16 2.2.3 Deutero Methanol (CD3 Od) 17 2.2.4 Deutero Water (D2O) 18 2.2.5 Deutero Benzene (C6d 6) 18 2.2.6 Carbon Tetrachloride (CCl 4) 18 2.2.7 Trifluoroacetic Acid (CF3Cooh) 18 2.2.8 Using Mixed Solvents 19 2.3 Spectrum Referencing (Proton NMR) 19 2.4 Sample Preparation 20 2.4.1 Filtration 21 3 Spectrum Acquisition 25 3.1 Number of Transients 25 3.2 Number of Points 26 3.3 Spectral Width 27 3.4 Acquisition Time 27 3.5 Pulse Width/Pulse Angle 27 3.6 Relaxation Delay 29 3.7 Number of Increments 29 3.8 Non-Uniform Sampling (NUS) 30 3.9 Shimming 30 3.10 Tuning and Matching 32 3.11 Frequency Lock 32 3.11.1 Run Unlocked 32 3.11.2 Internal Lock 32 3.11.3 External Lock 32 3.12 To Spin or Not to Spin? 33 4 Processing 35 4.1 Introduction 35 4.2 Zero-Filling and Linear Prediction 35 4.3 Apodization 36 4.4 Fourier Transformation 37 4.5 Phase Correction 37 4.6 Baseline Correction 40 4.7 Integration 40 4.8 Referencing 40 4.9 Peak Picking 41 5 Interpreting Your Spectrum 43 5.1 Common Solvents and Impurities 46 5.2 Group 1 – Exchangeables and Aldehydes 48 5.3 Group 2 – Aromatic and Heterocyclic Protons 50 5.3.1 Monosubstituted Benzene Rings 52 5.3.2 Multi-substituted Benzene Rings 55 5.3.3 Heterocyclic Ring Systems (Unsaturated) and Polycyclic Aromatic Systems 57 5.4 Group 3 – Double and Triple Bonds 61 5.5 Group 4 – Alkyl Protons 64 6 Delving Deeper 67 6.1 Chiral Centres 67 6.2 Enantiotopic and Diastereotopic Protons 72 6.3 Molecular Anisotropy 73 6.4 Accidental Equivalence 75 6.5 Restricted Rotation 77 6.6 Heteronuclear Coupling 81 6.6.1 coupling between Protons and 13 C 81 6.6.2 Coupling between Protons and 19 F 83 6.6.3 Coupling between Protons and 31 P 85 6.6.4 Coupling between 1H and Other Heteroatoms 87 6.7 Cyclic Compounds and the Karplus Curve 89 6.8 Salts, Free Bases and Zwitterions 93 6.9 Zwitterionic Compounds Are Worthy of Special Mention 94 7 Further Elucidation Techniques – Part 1 97 7.1 Chemical Techniques 97 7.1.1 Deuteration 97 7.1.2 Basification and Acidification 99 7.1.3 Changing Solvents 99 7.1.4 Trifluoroacetylation 100 7.1.5 Lanthanide Shift Reagents 101 7.1.6 Chiral Resolving Agents 102 8 Further Elucidation Techniques – Part 2 105 8.1 Introduction 105 8.2 Spin-Decoupling (Homonuclear, 1-D) 105 8.3 Correlated Spectroscopy (COSY) 106 8.4 Total Correlation Spectroscopy (TOCSY) 1- and 2-D 110 8.5 The Nuclear Overhauser Effect (NOE) and Associated Techniques 111 9 Carbon-13 NMR Spectroscopy 121 9.1 General Principles and 1-D 13 C 121 9.2 2-D Proton–Carbon (Single Bond) Correlated Spectroscopy 124 9.3 2-D Proton–Carbon (Multiple Bond) Correlated Spectroscopy 127 9.4 Piecing It All Together 130 9.5 Choosing the Right Tool 131 10 Nitrogen-15 NMR Spectroscopy 137 10.1 Introduction 137 10.2 Referencing 138 10.3 Using 15 N Data 138 10.4 Amines 141 10.4.1 Alkyl 141 10.4.2 Aryl 143 10.5 Conjugated Amines 145 10.6 Amides 145 10.7 Amidines 146 10.8 Azides 147 10.9 Carbamates 147 10.10 Cyanates and Thiocyanates 148 10.11 Diazo Compounds 149 10.12 Formamides 149 10.13 Hydrazines 150 10.14 Hydroxamic Acids 151 10.15 Hydroxylamines 152 10.16 Imides (Alkyl and Aryl) 152 10.17 Imines 152 10.18 Isocyanates and Isothiocyanates 153 10.19 Nitrogen-Bearing Heterocycles 154 10.20 Nitriles 157 10.21 Nitro Compounds 158 10.22 Nitroso and N-Nitroso Compounds 158 10.23 N-Oxides 159 10.24 Oximes 160 10.25 Sulfonamides 161 10.26 Ureas and Thioureas 162 10.27 Other Unusual Compounds 163 10.28 15 N Topics 166 10.28.1 1-, 2-, 3- and 4-bond Correlations 166 10.28.2 ‘Through-Space’ Correlations 168 10.28.3 Tautomerism in 15 N NMR 169 10.28.4 Restricted Rotation 170 10.28.5 Protonation and Zwitterions 170 11 Some Other Techniques and Nuclei 173 11.1 HPLC-NMR 173 11.2 Flow NMR 174 11.3 Solvent Suppression 175 11.4 MAS (Magic Angle Spinning) NMR 176 11.5 Pure Shift NMR 177 11.6 Other 2-D Techniques 178 11.6.1 INADEQUATE 178 11.6.2 J-Resolved 178 11.6.3 DOSY 178 11.7 3-D Techniques 179 11.8 Fluorine (19 F) NMR 180 11.9 Phosphorus (31 P) NMR 182 12 Dynamics 183 12.1 Linewidths 187 12.2 Chemical Shifts 187 12.3 Splittings 188 12.4 Relaxation Pathways 188 12.5 Experimental Techniques 188 12.6 In Practice 189 12.7 In Conclusion 191 13 Quantification 193 13.1 Introduction 193 13.2 Different Approaches to Quantification 193 13.2.1 Relative Quantification 193 13.2.2 Absolute Quantification 194 13.2.3 Internal Standards 194 13.2.4 External Standards 195 13.2.5 Electronic Reference (ERETIC) 195 13.2.6 QUANTAS196 13.2.7 ERETIC 2 196 13.3 Things to Watch Out For 197 13.4 Quantification of Other Nuclei 197 13.5 Conclusion 198 14 Safety 199 14.1 Magnetic Fields 199 14.2 Cryogens 201 14.3 Sample-Related Injuries 202 15 Software 203 15.1 Acquisition Software 203 15.2 Processing Software 204 15.3 Prediction and Simulation Software 205 15.3.1 13 C Prediction 205 15.3.2 1 H Prediction 207 15.3.3 Incremental Approaches 207 15.3.4 HOSE Code Databases 208 15.3.5 Semi-Empirical Approaches 208 15.3.6 Ab Initio Approaches 208 15.3.7 Neural Networks 208 15.5.8 Hybrid Approaches 209 15.5.9 Simulation 209 15.6 Structural Verification Software 209 15.7 Structural Elucidation Software 211 15.8 Summary 212 16 Problems 213 16.1 Questions 213 16.2 Hints 227 16.3 Answers 228 16.4 A Closing Footnote 241 17 Raising Your Game 243 17.1 Spotting the Pitfalls 243 17.2 The Wrong Solvent 244 17.3 Choosing the Right Experiment 245 Appendix A 261 Glossary 263 Index 269
£67.50
John Wiley and Sons Ltd Medical Genetics and Genomics
Book SynopsisTable of ContentsIntroduction vii 1 Basics and Terminology 1 2 Physical Examination 21 3 Clinical Diagnosis and Manifestations of Specific Conditions 49 4 Causes of Genetic Conditions and Laboratory and Testing Approaches 85 5 Management of Genetic Conditions and Therapeutics 129 6 Inheritance, Risk, and Related Calculations 143 Index 163
£44.99
Wiley-Blackwell Thermodynamics for Drug Product Design
£104.40
John Wiley & Sons Novel Drug Delivery Systems Fundamentals and
Book Synopsis
£162.00
Wiley-Blackwell The False Discovery Rate
Book Synopsis
£67.49
John Wiley and Sons Ltd Drug Utilization Research
Book Synopsis
£121.50
John Wiley & Sons Inc Two from One
Book SynopsisTable of ContentsForeword xii Preface xiv Symbols and Abbreviations xvi 1 History and Context 1 1.1 From Cells to Their Nuclei 1 1.1.1 The Cell Theory 2 1.1.2 Mitosis 3 1.1.3 The Chromosome Theory of Heredity 6 1.1.4 Deoxyribonucleic Acid (DNA) 9 1.1.5 Cell Cycles Come in Many Flavors 12 2 Cell Growth and Division 17 2.1 Balanced Growth and Cell Proliferation 17 2.2 Measures of Cell Growth 21 2.3 The Relationship Between Cell Growth and Division 24 2.4 Patterns of Growth in the Cell Cycle 27 2.4.1 Amoeba Cell Growth 28 2.4.2 Fission Yeast Growth 29 2.4.3 Budding Yeast Growth 30 2.4.4 Mammalian Cell Growth 31 2.5 Sizers vs Adders 32 3 Assaying Cell Cycle Progression 39 3.1 Measuring Cell Cycle Phases 39 3.1.1 Single- Cell Imaging 39 3.1.2 Labeled Mitoses 41 3.1.3 Frequency Distributions 43 3.2 Growth Limitations and Variations in the Duration of Cell Cycle Phases 46 3.3 Synchronous Cultures 49 3.3.1 How can One Induce Synchrony? 49 3.3.2 Selecting for Synchrony 52 3.3.2.1 Elutriation: The Mother of all Synchrony Selections 53 4 The Master Switch 57 4.1 Genetic Analyses Leading the Way 59 4.1.1 The cdc28 Mutant of Budding Yeast 59 4.1.2 From the wee1 to the cdc2 Mutant of Fission Yeast 63 4.1.3 What is True for One is True for All 66 4.2 All Roads Lead to the Same Control System 67 4.2.1 Cyclins 67 4.2.2 Maturation Promoting Factor (MPF) 70 4.3 Making Sense of it All 75 4.3.1 Cyclins Galore in Budding Yeast 76 4.3.1.1 G1 Cyclins 77 4.3.2 Back to wee1 78 5 Controlling the Master Switch 80 5.1 Cyclins in Cdk Complexes 81 5.2 Cdk as a Target of Phosphorylations 84 5.2.1 Activating Phosphorylation 84 5.2.2 Inhibitory Phosphorylation 85 5.3 Other Proteins in Cyclin/Cdk Complexes 86 5.3.1 Cdk Inhibitors 86 5.3.1.1 Cip/Kip Proteins 88 5.3.1.2 INK4 Proteins 88 5.3.2 Cks1 89 5.4 What Are Its Targets and How Cdk Phosphorylates Them 89 5.4.1 Defining the Cdk Substrate Universe 89 5.4.2 Cyclin the Recruiter 91 5.4.3 Here Comes Cks1 92 5.5 Ordering Cdk Phosphorylation in the Cell Cycle 94 5.5.1 Order from Intrinsic Cdk Activity 94 5.5.2 Precision from Specificity 96 6 A Full Circle of the Switch 99 6.1 Modeling a Cell Cycle Oscillator 99 6.2 The M- Cdk Switch 103 6.2.1 Exit from Interphase into Mitosis 103 6.2.2 The Anaphase Promoting Complex (apc) 104 6.2.3 From Metaphase to Anaphase 105 6.2.4 Flipping the M- Cdk Switch Off 106 6.2.5 Unsolved Problem: “Sizing” the M-.Cdk Switch 109 6.3 The G1/S Cdk Switch 110 6.3.1 G1- Cdk Activates G1/S Transcription 111 6.3.1.1 Doing Away with Transcriptional Inhibitors 111 6.3.2 Positive Feedback at the G1/S Switch 114 6.3.3 Negative Feedback at the G1/S Switch 115 6.3.4 Physiological Relevance of G1/S Switch in Cancer 116 6.4 Transcriptional Waves Until the End of the Cell Cycle 117 6.5 Comments on Overall Gene Expression in the Cell Cycle 119 7 Duplicating the Genome 121 7.1 DNA Replication 121 7.1.1 Setting the Stage 122 7.1.2 Origin Firing 126 7.1.3 Chromatin 128 7.1.4 Sisters Stay Together 129 7.2 Checkpoints 132 7.2.1 The General Concept 132 7.2.2 DNA Damage Checkpoint 134 8 Segregating the Chromosomes 138 8.1 Blind Men’s Riddle 138 8.2 The Mitotic Spindle 139 8.2.1 Tubulin 140 8.2.2 MTs are Dynamic 142 8.2.3 Scaling the Spindle 146 8.3 The MT Organizing Centers (MTOCs) 147 8.4 The Kinetochore 152 8.4.1 Kinetochore- MT Attachment: Stochastic or Deterministic? 154 8.4.2 May the Force Be With You 156 8.5 The Spindle Assembly Checkpoint (SAC) 159 9 Segregating Organelles and the Cytoplasm 162 9.1 The Golgi 164 9.2 Mitochondria 166 9.3 Lysosomes and Vacuoles 169 9.4 Mitotic Fragmentation of the Nuclear Envelope 170 9.5 Cytokinesis: Two from One 172 9.5.1 Position 172 9.5.2 Assemble 176 9.5.3 Contract 179 References 189 Index 209
£52.25
John Wiley and Sons Ltd Osteoporosis
Book SynopsisYou can reduce the risk of your patients suffering an osteoporosis-related fracture. Osteoporosis is a highly prevalent, treatable disease, but it is currently incurable. Successful early diagnosis can lead to effective treatment strategies that reduce the risk of a patient's life being compromised by serious fracture injury. In Osteoporosis, Dr Dale Stovall has assembled world-leading experts who guide you through modern best-practice approaches to: Diagnosis of osteoporosis Risk assessment for fractures Use of calcium and vitamin D Medical therapy and follow up Future approaches to treatment Osteoporosis empowers you to identify and treat your patients with osteoporosis and low bone mass, preventing subsequent fractures and improving their quality of life.Table of ContentsList of Contributors, vii Preface, ix 1 Epidemiology and Genetics of Postmenopausal Osteoporosis, 1 Mark Edwards, Rebecca Moon, Nick Harvey & Cyrus Cooper 2 Osteoporosis in Men, 15 Robert A. Adler 3 Mechanisms of Bone Remodeling, 31 Maziar Shabestari & Erik Fink Eriksen 4 Fracture Risk Assessment, 46 Ronald C. Hamdy 5 Secondary Causes of Osteoporosis: Bone Diseases, 62 Peter R. Ebeling 6 Glucocorticoid-induced Osteoporosis, 79 Stuart Silverman & Swamy Venuturupalli 7 Secondary Causes of Osteoporosis: Other Medications, 93 Diane M. Biskobing 8 Hormone Therapy for Osteoporosis, 108 Pilar Valenzuela Mazo & James A. Simon 9 Bisphosphonates, 123 Paul D. Miller & Nelson B. Watts 10 Denosumab, 144 Michael A. Bolognese 11 Parathyroid Hormone: Anabolic Treatment of Osteoporosis, 158 Erik Fink Eriksen 12 Optimum Calcium and Vitamin D for the Prevention and Treatment of Osteoporosis, 178 Michael F. Holick 13 The Use of Combination Therapy in the Treatment of Postmenopausal Osteoporosis, 201 Juliet Compston 14 Emerging Therapies, 211 Michael R. McClung & Cristiano A. F. Zerbini 15 Monitoring Therapy for Osteoporosis, 227 E. Michael Lewiecki 16 Persistence and Compliance with Medications to Prevent Fractures: Epidemiology, Etiology, and Management Issues, 239 John T. Schousboe Appendix: A Clinician’s Approach to the Patient, 263 Robert Lindsay Index, 273
£89.06
Wiley-Blackwell Cholesterol Lipoproteins and Cardiovascular
Book SynopsisDiscover the biology, biochemistry, and medical aspects of lipoproteins in this comprehensive overview of its historic and contemporary development The fatty substance known as cholesterol is found in every cell of the human body and carries out several important functions. It is transported through the bloodstream as a part of particles called lipoproteins, which are divided into classes including low-density lipoprotein (LDL) and high-density lipoprotein (HDL). Distinguishing between these two classes, along with the remnant cholesterol' particles that have recently been associated with heightened risk of heart disease and stroke, is a crucial part of managing health and developing novel pharmaceuticals. Cholesterol, Lipoproteins, and Cardiovascular Health offers a thorough and rigorous overview of these particles, their properties, and their methods of categorization. Surveying both the characteristics of lipoproteins and their interactions with diet, lifestyl
£90.00
£63.00
John Wiley & Sons Inc Nanoscience and Nanotechnology for Smart Prevention Diagnostics and Therapeutics
Book SynopsisThe book presents the fundamentals of nanomaterials, discusses the direct applications of nanomaterials to the biomedical sector, and explores the potential therapeutic applications of nanotheranostics. This book focuses on the fundamental features of various nanomaterials that are related to the development of biomedical technologies. These fundamental qualities are broken up into three parts: prevention, diagnostics, and therapeutics. When it comes to infectious diseases, prevention is of the utmost importance. Highly advanced nanomaterials including silver, titanium, graphene-based filters, and copper nanoparticles are used to fight infectious illnesses. Once the symptoms have been recognized in the patients, through the use of effective and straightforward nanodiagnostic techniques, the diseases can be accurately localized in either a qualitative or quantitative manner. Nanodiagnostics tools currently dominate the field of biomedical diagnostics because of their high d
£153.00
Not Stated Secondary Metabolites and Drug Discovery
£161.50
John Wiley & Sons Inc Care of Older People with Diabetes
Book SynopsisA concise and accessible overview to the treatment of diabetes in older patients Care of older people is rapidly becoming one of the most important components of the healthcare profession. An aging population provides new challenges for the healthcare industry and drives new demand for healthcare professionals with dedicated elder care experience and training. Few aspects of care for older patients are more important than diabetes, a condition characterized by its unique challenges and clinical heterogeneity. Care of Older People with Diabetes offers a concise and readable introduction to the essentials of this vital clinical practice. Building on the knowledge contained within the successful Diabetes in Old Age textbook series, this book brings to bear the work of global experts in the field to provide a working reference for students and early career healthcare professionals alike. Anyone with an interest in caring for older patients with diabetes should find this a lucid and invalua
£90.00
John Wiley & Sons Inc Leukaemia Diagnosis
Book Synopsis
£134.99
Wiley-Blackwell Chemistry and Pharmacology of Drug Discovery
Book SynopsisCase studies of 20 successful FDA-approved drugs, from biological rationale to clinical efficacy studies and state-of-the-art applications Chemistry and Pharmacology of Drug Discovery illustrates how chemistry, biology, pharmacokinetics, and a host of disciplines come together to produce successful medicines, discussing a total of 20 drugs that are all FDA-approved post 2021some of which are first-in-class and revolutionary. The four sections in this book cover Infectious Disease, Cancer Drugs, CNS Drugs, and Miscellaneous Drugs. Each chapter covers background material on the drug class and/or disease indication and key aspects relevant to the discovery of the drug, including structure-activity relationships, pharmacokinetics, drug metabolism, efficacy, and safety. This book is contributed to by various veterans and well-known experts in medical chemistry, many of whom discovered the drugs they reviewed, leading to tremendous quality and depth of insight. Some of the drugs covered in C
£140.40
Wiley-Blackwell Skin Lymphoma
£143.99
John Wiley & Sons Inc Laser Therapy in Healthcare
Book SynopsisThe book explores the intersection of laser technology and healthcare, highlighting its applications, challenges, and potential future in medical practice. Implementing cutting-edge technologies has upended the paradigms of diagnosis and treatment in the ever-changing world of healthcare. Among these breakthroughs, the introduction of laser therapy stands out as a transformative moment, presenting a tremendous range of possibilities across a wide range of medical areas. This book is the outcome of considerable research, combined experience, and a passionate study of lasers' diverse uses in modern medicine. This thorough book navigates the complex field of laser physics, clinical applications, and novel treatment interventions that are transforming the healthcare sector. This book acts as a roadmap through the various aspects of laser-based diagnostics and treatment modalities, from the basic chapters that explain the fundamentals of laser physics and its significant
£140.40
John Wiley & Sons Artificial IntelligenceBased System Models in
Book Synopsis
£180.00
